<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32312822</article-id>
<article-id pub-id-type="pmc">7211998</article-id>
<article-id pub-id-type="publisher-id">201908238</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1908238117</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Loss of the neural-specific BAF subunit ACTL6B relieves repression of early response genes and causes recessive autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wenderski</surname>
<given-names>Wendy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krokhotin</surname>
<given-names>Andrey</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walsh</surname>
<given-names>Jessica J.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Hongjie</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>i</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-4843-6949</contrib-id>
<name>
<surname>Shoji</surname>
<given-names>Hirotaka</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>j</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghosh</surname>
<given-names>Shereen</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>George</surname>
<given-names>Renee D.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>Erik L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elias</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gillespie</surname>
<given-names>Mark A.</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>k</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Son</surname>
<given-names>Esther Y.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Staahl</surname>
<given-names>Brett T.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baek</surname>
<given-names>Seung Tae</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanley</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moncada</surname>
<given-names>Cynthia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shipony</surname>
<given-names>Zohar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Linker</surname>
<given-names>Sara B.</given-names>
</name>
<xref ref-type="aff" rid="aff13">
<sup>l</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marchetto</surname>
<given-names>Maria C. N.</given-names>
</name>
<xref ref-type="aff" rid="aff13">
<sup>l</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-0938-4106</contrib-id>
<name>
<surname>Gage</surname>
<given-names>Fred H.</given-names>
</name>
<xref ref-type="aff" rid="aff13">
<sup>l</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Dillon</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sultan</surname>
<given-names>Tipu</given-names>
</name>
<xref ref-type="aff" rid="aff14">
<sup>m</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zaki</surname>
<given-names>Maha S.</given-names>
</name>
<xref ref-type="aff" rid="aff15">
<sup>n</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ranish</surname>
<given-names>Jeffrey A.</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>k</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-0137-8200</contrib-id>
<name>
<surname>Miyakawa</surname>
<given-names>Tsuyoshi</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>j</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-5467-9264</contrib-id>
<name>
<surname>Luo</surname>
<given-names>Liqun</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>i</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Malenka</surname>
<given-names>Robert C.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crabtree</surname>
<given-names>Gerald R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-0889-9220</contrib-id>
<name>
<surname>Gleeson</surname>
<given-names>Joseph G.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Pathology, <institution>Stanford Medical School</institution>, Palo Alto, <addr-line>CA</addr-line> 94305;</aff>
<aff id="aff2"><sup>b</sup>Department of Genetics, <institution>Stanford Medical School</institution>, Palo Alto, <addr-line>CA</addr-line> 94305;</aff>
<aff id="aff3"><sup>c</sup>Department of Developmental Biology, <institution>Stanford Medical School</institution>, Palo Alto, <addr-line>CA</addr-line> 94305;</aff>
<aff id="aff4"><sup>d</sup><institution>Howard Hughes Medical Institute</institution>, <institution>Stanford University</institution>, Palo Alto, <addr-line>CA</addr-line> 94305;</aff>
<aff id="aff5"><sup>e</sup>Department of Neuroscience, <institution>University of California San Diego</institution>, La Jolla, <addr-line>CA</addr-line> 92037;</aff>
<aff id="aff6"><sup>f</sup><institution>Howard Hughes Medical Institute</institution>, <institution>University of California San Diego</institution>, La Jolla, <addr-line>CA</addr-line> 92037;</aff>
<aff id="aff7"><sup>g</sup>Rady Children’s Institute of Genomic Medicine, <institution>University of California San Diego</institution>, La Jolla, <addr-line>CA</addr-line> 92037;</aff>
<aff id="aff8"><sup>h</sup>Nancy Pritztker Laboratory, Department of Psychiatry and Behavioral Sciences, <institution>Stanford Medical School</institution>, Palo Alto, <addr-line>CA</addr-line> 94305;</aff>
<aff id="aff9"><sup>i</sup>Department of Biology, <institution>Stanford University</institution>, Palo Alto, <addr-line>CA</addr-line> 94305;</aff>
<aff id="aff10"><sup>j</sup>Division of Systems Medical Science, Institute for Comprehensive Medical Science, <institution>Fujita Health University</institution>, 470-1192 Toyoake, Aichi, <country>Japan</country>;</aff>
<aff id="aff12"><sup>k</sup><institution>Institute for Systems Biology</institution>, Seattle, <addr-line>WA</addr-line> 98109;</aff>
<aff id="aff13"><sup>l</sup>Laboratory of Genetics, <institution>The Salk Institute for Biological Studies</institution>, La Jolla, <addr-line>CA</addr-line> 92037;</aff>
<aff id="aff14"><sup>m</sup>Department of Pediatric Neurology, Institute of Child Health, <institution>Children Hospital Lahore</institution>, 54000 Lahore, <country>Pakistan</country>;</aff>
<aff id="aff15"><sup>n</sup>Clinical Genetics Department, Human Genetics and Genome Research Division, <institution>National Research Centre</institution>, 12311 Cairo, <country>Egypt</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence may be addressed. Email: <email>crabtree@stanford.edu</email> or <email>jogleeson@ucsd.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Arthur L. Beaudet, Baylor College of Medicine, Houston, TX, and approved March 9, 2020 (received for review May 20, 2019)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: W.W., J.J.W., H.L., H.S., E.L.M., L.E., F.H.G., T.M., L.L., R.C.M., G.R.C., and J.G.G. designed research; W.W., L.W., A.K., J.J.W., H.L., H.S., S.G., L.E., M.A.G., E.Y.S., B.T.S., C.M., S.B.L., M.C.N.M., T.S., M.S.Z., and J.G.G. performed research; W.W., L.W., S.T.B., V.S., Z.S., F.H.G., J.A.R., T.M., L.L., R.C.M., G.R.C., and J.G.G. contributed new reagents/analytic tools; W.W., L.W., A.K., J.J.W., H.L., H.S., R.D.G., M.A.G., E.Y.S., B.T.S., S.T.B., V.S., C.M., Z.S., D.C., and J.G.G. analyzed data; W.W., G.R.C., and J.G.G. wrote the paper; A.K. helped to write a section of the paper; and S.G. contributed preliminary data that helped inform our decision to switch to the brain organoid system.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>L.W. and A.K. contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>5</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>4</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>117</volume>
<issue>18</issue>
<fpage>10055</fpage>
<lpage>10066</lpage>
<permissions>
<copyright-statement>Copyright © 2020 the Author(s). Published by PNAS.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
<license-p>This open access article is distributed under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND)</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201908238.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Autism is a complex neurodevelopmental disorder whose causative mechanisms are unclear. Taking advantage of a unique cohort with recessively inherited autism, we identified six families with biallelic mutation of the neuronal-specific subunit of the BAF complex, <italic>ACTL6B</italic> (also known as <italic>BAF53b</italic>). Relative to all other genes, <italic>ACTL6B</italic> was the most statistically significant mutated gene in the recessive autism cohort. We describe autism-relevant phenotypes in human brain organoids and in mouse and fly models. We foresee the outcomes from this study will be the following: 1) a link between neuronal activity-dependent transcriptional repression and autism; 2) a characterization of mouse and fly models to study <italic>ACTL6B</italic> mutant autism; and 3) an understanding the role of ACTL6B and nBAF complexes in neuronal transcriptional regulation.</p>
</abstract>
<abstract>
<p>Synaptic activity in neurons leads to the rapid activation of genes involved in mammalian behavior. ATP-dependent chromatin remodelers such as the BAF complex contribute to these responses and are generally thought to activate transcription. However, the mechanisms keeping such “early activation” genes silent have been a mystery. In the course of investigating Mendelian recessive autism, we identified six families with segregating loss-of-function mutations in the neuronal BAF (nBAF) subunit <italic>ACTL6B</italic> (originally named <italic>BAF53b</italic>). Accordingly, <italic>ACTL6B</italic> was the most significantly mutated gene in the Simons Recessive Autism Cohort. At least 14 subunits of the nBAF complex are mutated in autism, collectively making it a major contributor to autism spectrum disorder (ASD). Patient mutations destabilized ACTL6B protein in neurons and rerouted dendrites to the wrong glomerulus in the fly olfactory system. Humans and mice lacking <italic>ACTL6B</italic> showed corpus callosum hypoplasia, indicating a conserved role for <italic>ACTL6B</italic> in facilitating neural connectivity. <italic>Actl6b</italic> knockout mice on two genetic backgrounds exhibited ASD-related behaviors, including social and memory impairments, repetitive behaviors, and hyperactivity. Surprisingly, mutation of <italic>Actl6b</italic> relieved repression of early response genes including AP1 transcription factors (<italic>Fos</italic>, <italic>Fosl2</italic>, <italic>Fosb</italic>, and <italic>Junb</italic>), increased chromatin accessibility at AP1 binding sites, and transcriptional changes in late response genes associated with early response transcription factor activity. <italic>ACTL6B</italic> loss is thus an important cause of recessive ASD, with impaired neuron-specific chromatin repression indicated as a potential mechanism.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>mouse model</kwd>
<kwd>recessive</kwd>
<kwd>BAF</kwd>
<kwd>activity dependent</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp1">NS046789</award-id>
<principal-award-recipient>Wendy Wenderski</principal-award-recipient>
<principal-award-recipient>Jessica J Walsh</principal-award-recipient>
<principal-award-recipient>Shereen Ghosh</principal-award-recipient>
<principal-award-recipient>Gerald R. Crabtree</principal-award-recipient>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">Simons Foundation<named-content content-type="funder-id">100000893</named-content></funding-source>
<award-id rid="sp2">514863</award-id>
<principal-award-recipient>Robert Malenka</principal-award-recipient>
<principal-award-recipient>Gerald R. Crabtree</principal-award-recipient>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp3">R01NS048453</award-id>
<principal-award-recipient>Wendy Wenderski</principal-award-recipient>
<principal-award-recipient>Jessica J Walsh</principal-award-recipient>
<principal-award-recipient>Shereen Ghosh</principal-award-recipient>
<principal-award-recipient>Gerald R. Crabtree</principal-award-recipient>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">Qatar National Research Fund (QNRF)<named-content content-type="funder-id">100008982</named-content></funding-source>
<award-id rid="sp4">QNRF NPRP 6-1463-3-351</award-id>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
<award-group id="gs5">
<funding-source id="sp5">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp5">1F31MH116588-01</award-id>
<principal-award-recipient>Wendy Wenderski</principal-award-recipient>
</award-group>
<award-group id="gs6">
<funding-source id="sp6">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp6">2T32GM007790-38</award-id>
<principal-award-recipient>Wendy Wenderski</principal-award-recipient>
<principal-award-recipient>Jessica J Walsh</principal-award-recipient>
<principal-award-recipient>Shereen Ghosh</principal-award-recipient>
<principal-award-recipient>Gerald R. Crabtree</principal-award-recipient>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
<award-group id="gs7">
<funding-source id="sp7">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp7">5T32GM008666</award-id>
<principal-award-recipient>Wendy Wenderski</principal-award-recipient>
<principal-award-recipient>Jessica J Walsh</principal-award-recipient>
<principal-award-recipient>Shereen Ghosh</principal-award-recipient>
<principal-award-recipient>Gerald R. Crabtree</principal-award-recipient>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
<award-group id="gs8">
<funding-source id="sp8">Simons Foundation<named-content content-type="funder-id">100000893</named-content></funding-source>
<award-id rid="sp8">305112</award-id>
<principal-award-recipient>Robert Malenka</principal-award-recipient>
<principal-award-recipient>Gerald R. Crabtree</principal-award-recipient>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
<award-group id="gs9">
<funding-source id="sp9">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp9">F32MH103949</award-id>
<principal-award-recipient>Wendy Wenderski</principal-award-recipient>
<principal-award-recipient>Jessica J Walsh</principal-award-recipient>
<principal-award-recipient>Shereen Ghosh</principal-award-recipient>
<principal-award-recipient>Gerald R. Crabtree</principal-award-recipient>
<principal-award-recipient>Joseph G. Gleeson</principal-award-recipient>
</award-group>
</funding-group>
<counts>
<page-count count="12"></page-count>
</counts>
</article-meta>
</front>
<body>
<p content-type="flushleft">Autism spectrum disorder (ASD) represents a heterogeneous group of neurodevelopmental disorders that are characterized by social deficits and restricted or repetitive behaviors, and affect ∼1% of children worldwide (<xref ref-type="bibr" rid="r1">1</xref>, <xref ref-type="bibr" rid="r2">2</xref>). The heritability of ASD is estimated to be ∼80% (<xref ref-type="bibr" rid="r3">3</xref>), implicating genetic mutation as the prominent cause of autism. Indeed, exome-sequencing studies have identified hundreds of genetic mutations that substantially increase ASD risk (<xref ref-type="bibr" rid="r4">4</xref>). Among the most frequently mutated genes in ASD are subunits of the mammalian SWI/SNF (BAF) ATP-dependent chromatin remodeling complex (<xref ref-type="bibr" rid="r4">4</xref>). BAF complexes facilitate dynamic changes in gene expression by controlling DNA accessibility to the transcriptional machinery (<xref ref-type="bibr" rid="r5">5</xref>). To accomplish this, BAF complexes mobilize nucleosomes, evict polycomb repressive complexes, and recruit type II topoisomerases that decatenate DNA (<xref ref-type="bibr" rid="r6">6</xref><xref ref-type="bibr" rid="r7"></xref><xref ref-type="bibr" rid="r8"></xref>–<xref ref-type="bibr" rid="r9">9</xref>).</p>
<p>Although present in all cells, BAF complexes orchestrate cell type-specific functions through combinatorial assembly of ∼15 subunits from the products of 29 genes (<xref ref-type="bibr" rid="r5">5</xref>). During neural development, exit from the cell cycle is accompanied by BAF subunit exchange: neural progenitor (np) subunits ACTL6A (BAF53a), DPF2/PHF10 (BAF45a/d), and SS18 are exchanged for neuron-specific (n) subunits ACTL6B (BAF53b), DPF1/3 (BAF45b/c), and SS18L1 (CREST), respectively (<xref ref-type="bibr" rid="r10">10</xref><xref ref-type="bibr" rid="r11"></xref><xref ref-type="bibr" rid="r12"></xref>–<xref ref-type="bibr" rid="r13">13</xref>). Subunit exchange is critical for neuronal function, as genetic deletion of either <italic>ACTL6B</italic> or <italic>SS18L1</italic> impairs activity-dependent dendritic arborization (<xref ref-type="bibr" rid="r14">14</xref>, <xref ref-type="bibr" rid="r15">15</xref>). Furthermore, expression of the two microRNAs, miR9* and miR124, which control BAF subunit switching, is sufficient to convert fibroblasts into neurons (<xref ref-type="bibr" rid="r13">13</xref>).</p>
<p>Recent findings link mutations in nearly every constitutive member of the BAF complex to ASD or intellectual disability (ID), including syndromic forms such as Coffin–Siris and Nicolaides–Baraitser syndromes (<xref ref-type="bibr" rid="r16">16</xref><xref ref-type="bibr" rid="r17"></xref>–<xref ref-type="bibr" rid="r18">18</xref>). Implicated subunits include the following (protein/gene): BAF250b/<italic>ARID1B</italic>, BAF250a/<italic>ARID1A</italic>, BAF200/<italic>ARID2</italic>, BCL11A/<italic>BCL11A</italic>, BRG1/<italic>SMARCA4</italic>, BRM/<italic>SMARCA2</italic>, BAF155/<italic>SMARCC1</italic>, BAF170/<italic>SMARCC2</italic>, BAF45a/<italic>PHF10</italic>, BAF45d/<italic>DPF2</italic> BAF47/<italic>SMARCB1</italic>, BAF57/<italic>SMARCE1</italic>, BAF53a/<italic>ACTL6A</italic>, BAF53b/<italic>ACTL6B</italic>, BAF60a/<italic>SMARCD1</italic>, and β-actin/<italic>ACTB</italic> (<xref ref-type="bibr" rid="r17">17</xref>, <xref ref-type="bibr" rid="r19">19</xref><xref ref-type="bibr" rid="r20"></xref><xref ref-type="bibr" rid="r21"></xref><xref ref-type="bibr" rid="r22"></xref><xref ref-type="bibr" rid="r23"></xref><xref ref-type="bibr" rid="r24"></xref><xref ref-type="bibr" rid="r25"></xref><xref ref-type="bibr" rid="r26"></xref><xref ref-type="bibr" rid="r27"></xref><xref ref-type="bibr" rid="r28"></xref>–<xref ref-type="bibr" rid="r29">29</xref>). BAF mutant forms of ASD share overlapping clinical features such as corpus callosal hypoplasia, epilepsy, ID, lack of speech, craniofacial abnormalities, developmental delays, and fifth-digit shortening (<xref ref-type="bibr" rid="r17">17</xref>). The mechanisms through which BAF subunit mutations give rise to ASD are unclear.</p>
<sec id="s1" sec-type="results">
<title>Results</title>
<sec id="s2">
<title>Biallelic Inherited Mutations in <italic>ACTL6B</italic> Cause Recessive Autism.</title>
<p>Phenotypic and genotypic heterogeneity in ASD make this a challenging disorder to study at the molecular level. Distinct molecular mechanisms may underlie social deficits and repetitive behaviors, as well as ID, epilepsy, sleep and mood disorders, hyperactivity, and systemic issues that are frequently comorbid with autism (<xref ref-type="bibr" rid="r30">30</xref>). Because autism mutations are predominantly de novo and can occur in genes that function in a variety of tissues during development (<xref ref-type="bibr" rid="r4">4</xref>, <xref ref-type="bibr" rid="r16">16</xref>, <xref ref-type="bibr" rid="r21">21</xref>, <xref ref-type="bibr" rid="r31">31</xref>), it can also be difficult to define the relevant developmental and cellular contexts in which to study ASD mechanisms. Finally, many ASD mutations increase susceptibility but do not consistently cause autism phenotypes in humans or in animal models (<xref ref-type="bibr" rid="r32">32</xref>, <xref ref-type="bibr" rid="r33">33</xref>).</p>
<p>One strategy to uncover causative mechanisms in ASD is to study families with recessively inherited autism, since it is rare for two copies of a mutant gene to segregate perfectly with recessive autism by chance. Thus, we studied 135 ASD probands from consanguineous marriages recruited for the Simons Recessive Autism Cohort (SRAC) (<xref ref-type="bibr" rid="r34">34</xref><xref ref-type="bibr" rid="r35"></xref><xref ref-type="bibr" rid="r36"></xref>–<xref ref-type="bibr" rid="r37">37</xref>). Genomic DNA underwent whole-exome sequencing and were compared with a cohort of 256 controls with recessive neurodevelopmental disease (NDD) without ASD (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Supplementary Text</ext-link>). To identify significantly mutated genes, we generated quartile–quartile (Q-Q) plots comparing the observed to expected number of damaging recessive genotypes (deletion, frameshift/stop, or damaging missense) in the SRAC vs. non-ASD recessive NDD cohorts. When considering all coding genes, only <italic>ACTL6B</italic>, a subunit of the nBAF complex, and <italic>CD36</italic>, a fatty acid translocase and scavenger receptor (<xref ref-type="bibr" rid="r38">38</xref>), showed genome-wide significance for mutations in the SRAC (<xref ref-type="fig" rid="fig01">Fig. 1 <italic>A</italic> and <italic>C</italic></xref>). Limiting to just loss of function (LoF)-intolerant genes (i.e., those with pLI ≥ 0.9) left only <italic>ACTL6B</italic> with genome-wide significance (<italic>P</italic> &lt; 10<sup>−14</sup>) (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S1<italic>A</italic></ext-link>). A similar statistical analysis was conducted on the non-ASD NDD cohort of 256 individuals of similar genetic background, matched for consanguinity. The non-ASD NDD cohort showed enrichment for genes previously implicated in non-ASD NDD (<xref ref-type="bibr" rid="r39">39</xref>) but not <italic>ACTL6B</italic> (<xref ref-type="fig" rid="fig01">Fig. 1<italic>B</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S1<italic>B</italic></ext-link>). To test whether <italic>ACTL6B</italic> mutations were enriched in a genetically distinct recessive autism cohort, we rank ordered 409 genes with recessive missense variants in the Autism Sequencing Consortium by their RAFT <italic>P</italic> value and found that <italic>ACTL6B</italic> was the sixth most significantly mutated gene (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S1<italic>C</italic></ext-link>) (<xref ref-type="bibr" rid="r25">25</xref>). Individuals with recessive ASD-like phenotypes linked to biallelic <italic>ACTL6B</italic> mutations have also been identified in recent case studies (<xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r40">40</xref>, <xref ref-type="bibr" rid="r41">41</xref>). Cumulatively, these findings implicate mutations in <italic>ACTL6B</italic> as an important cause of recessive autism.</p>
<fig fig-type="featured" id="fig01" orientation="portrait" position="float">
<label>Fig. 1.</label>
<caption>
<p>Biallelic mutations in <italic>ACTL6B</italic> cause recessive autism. (<italic>A</italic>) Q-Q plot showing the observed/expected number of mutations for all coding genes in the SRAC. <italic>ACTL6B</italic> and <italic>CD36</italic> were significantly mutated. (<italic>B</italic>) Q-Q plot showing the observed/expected number of mutations for all coding genes in a genetically matched non-ASD recessive neurodevelopmental cohort, where <italic>ACTL6B</italic> was not found to be enriched. (<italic>C</italic>) <italic>ACTL6B</italic> encodes a tissue-restricted subunit of the neuronal (nBAF) BAF complex. Representation of the multisubunit nBAF complex containing ubiquitously expressed subunits (gray), a core ATPase subunit (dark blue), and neuronal-specific subunits (yellow) including ACTL6B in bold. The balls on a string represent nucleosomes. (<italic>D</italic>) Recessive ASD inheritance with <italic>ACTL6B</italic> mutations in six independent consanguineous families. Double lines, first cousin status; squares, males; circles, females; slash-through, mortality; black fill, ASD. Missense variants (green) and truncating variants (blue). Obligate carriers depicted with dot at center of symbol.</p>
</caption>
<graphic id="gra1" xlink:href="pnas.1908238117fig01"></graphic>
</fig>
<p>Focusing on <italic>ACTL6B</italic>, we more closely examined the patient phenotype and sought to understand how mutations in this gene give rise to autism. Six families representing 4.4% of the SRAC cohort demonstrated homozygous variants in <italic>ACTL6B</italic> with fully penetrant recessive inheritance (<xref ref-type="fig" rid="fig01">Fig. 1<italic>D</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Table S1</ext-link>). Variants were not present in ExAC or gnomAD databases, nor in ethnically matched controls from the Greater Middle East Variome or the cohort of 256 controls (<xref ref-type="bibr" rid="r42">42</xref>, <xref ref-type="bibr" rid="r43">43</xref>), indicating that they are rare variants. Subjects exhibited nonverbal autism with stereotypies, as well as ID, developmental delay, hyperactivity, and mild spasticity (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Table S2</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Movie S1</ext-link>). There were no syndromic features that would have identified these patients as unique a priori from other SRAC subjects (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Table S2 and Supplementary Text</ext-link>). Epilepsy was seen in all subjects, presenting at 2 wk to 5 y of age, and generally responded to anticonvulsant medication. Males and females were similarly affected, consistent with fully penetrant inheritance. While the SRAC patients were of Middle Eastern descent, similar phenotypes have been reported for <italic>ACTL6B</italic> mutant individuals of French-Canadian, Sicilian, and Finnish descent (<xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r40">40</xref>, <xref ref-type="bibr" rid="r41">41</xref>, <xref ref-type="bibr" rid="r44">44</xref>, <xref ref-type="bibr" rid="r45">45</xref>). The high penetrance and perfect segregation of mutant alleles with ASD indicate a causal relationship between <italic>ACTL6B</italic> mutation and autism. This distinguishes <italic>ACTL6B</italic> from most other autism-associated genes, which substantially increase risk when mutated, but alone may not be sufficient to cause disease.</p>
</sec>
<sec id="s3">
<title>Patient Mutations Destabilize ACTL6B and Reduce Its Incorporation into the BAF Complex.</title>
<p>Consistent with the recessive mode of inheritance, patient variants were protein truncating, frame shifting, or missense for highly conserved residues (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S2 <italic>A</italic>–<italic>C</italic></ext-link>). Variants occurred throughout the open reading frame, arguing against dominant-negative effects. Gibbs free energy calculations revealed that the missense variants likely disrupt protein folding, in line with PolyPhen-2 “damaging” predictions (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S2<italic>D</italic></ext-link>). To visualize how the patient mutations are oriented in relation to the BAF complex, we generated a protein model of human ACTL6B binding to the conserved HSA domain of SMARCA4. This revealed two patient missense variants (L154F and G393R) located in residues that are critical for stabilizing the hydrophobic binding interface between ACTL6B and SMARCA4 (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S2<italic>E</italic></ext-link>), consistent with a LoF disease mechanism.</p>
<p>To test these predictions in vitro, we assessed ACTL6B missense mutant protein expression and incorporation into BAF complexes in the HEK293T cell line, human embryonic stem cells, and <italic>Actl6b</italic><sup><italic>−/−</italic></sup> primary mouse neurons. To rule out the effects of species or cellular context, we also derived induced pluripotent stem cells (iPSCs) from control or affected humans in family 2703 (<italic>ACTL6B</italic><sup><italic>L154F/L154F</italic></sup>) and conducted neural differentiation over 8 wk. RNA sequencing (RNA-seq) of (<italic>n</italic> = 3) control individuals confirmed that the switch of progenitor BAF subunits for nBAF subunits (<xref ref-type="bibr" rid="r11">11</xref>) was conserved in humans, as indicated from down-regulation of nonneuronal <italic>ACTL6A</italic> and up-regulation of <italic>ACTL6B</italic> (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S3 <italic>A</italic> and <italic>B</italic></ext-link>). In each cellular context, ACTL6B mutant protein expression was dramatically reduced relative to wild type, with little to no mutant protein incorporated into neuronal or nonneuronal BAF (<xref ref-type="fig" rid="fig02">Fig. 2 <italic>A</italic>–<italic>D</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S4 <italic>A</italic>–<italic>E</italic></ext-link>). These data suggest that the patient mutations destabilize ACTL6B protein and result in the formation of nBAF complexes that lack ACTL6B.</p>
<fig fig-type="figure" id="fig02" orientation="portrait" position="float">
<label>Fig. 2.</label>
<caption>
<p>Patient mutations destabilize ACTL6B protein and cause a loss-of-function “perfect dendritic retargeting” phenotype in the fly olfactory system. (<italic>A</italic>) Patient missense mutant proteins were less stable than wild-type ACTL6B when expressed in HEK293T cells; <italic>n</italic> = 2 for T175P and G417W; <italic>n</italic> = 4 for wild type, L154F, and G393R. (<italic>B</italic>) Endogenous ACTL6B protein was decreased in human neurons derived from iPSCs of two affected individuals (<italic>ACTL6B</italic><sup><italic>L154F/L154F</italic></sup>) in family 2703 relative to the wild-type control; <italic>n</italic> = 3 replicates. Neurofilament light chain, a mature neuronal marker that confirms differentiation status. (<italic>C</italic>) Missense mutant proteins were less stable than wild-type ACTL6B when expressed for 2 wk in cultured striatal neurons from <italic>Actl6b</italic><sup><italic>−/−</italic></sup> E18.5 mice; <italic>n</italic> = 2. (<italic>D</italic>) Missense mutant proteins showed decreased recovery following coimmunoprecipitation with SMARCA4 from striatal neurons shown in <italic>C</italic>; <italic>n</italic> = 1 (see similar results in cortical neurons, human ESCs, and HEK293Ts shown in <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S4 <italic>B</italic>–<italic>E</italic></ext-link>). (<italic>E</italic>) MARCM (mosaic analysis with a repressible cell marker) was used to fluorescently label and replace fly <italic>Bap55</italic> with human <italic>ACTL6B</italic> alleles in olfactory projection neurons (PNs). PNs always project a dendrite to the dorsolateral glomerulus (DL1) in the posterior antennal lobe. Clones were induced in GH146-GAL4 flies at a time when DL1 PNs were born. Replacement of the fly ortholog with human wild-type <italic>ACTL6B</italic> but not patient variants (L154F or G393R) rescued the perfect dendritic retargeting phenotypes in single-neuron clones. Arrows, cell bodies; Ncad, neuropil marker. (Scale bar, 20 µm.) (<italic>F</italic>) Quantification of <italic>E</italic> where single PNs were correctly targeted to DL1 or mistargeted to DA4l or DM6; <italic>n</italic> = animals per condition.</p>
</caption>
<graphic id="gra2" xlink:href="pnas.1908238117fig02"></graphic>
</fig>
</sec>
<sec id="s4">
<title>Patient Mutations Produce LoF “Perfect Dendritic Retargeting” Phenotype in Fly Brain.</title>
<p>Social communication is a key defect in ASD (<xref ref-type="bibr" rid="r30">30</xref>). In insects, social communication is dependent upon olfactory cues (<xref ref-type="bibr" rid="r46">46</xref>) and specifically olfactory projection neurons, which transmit signals to specific glomeruli in a stereotyped manner. Previously, human <italic>ACTL6B</italic> was shown to genetically complement the fly ortholog <italic>Bap55</italic> and rescue a LoF “perfect dendritic retargeting” phenotype in the fly olfactory system, where dendritic trees project cell autonomously to the wrong glomerulus with 100% expressivity (<xref ref-type="bibr" rid="r47">47</xref>). This results in a switch in synaptic specificity that may affect how the fly interprets chemical cues. Using the mosaic analysis with a repressible cell marker (MARCM) method (<xref ref-type="bibr" rid="r48">48</xref>), we simultaneously replaced the fly ortholog with human wild-type or ASD mutant <italic>ACTL6B</italic> and expressed GFP in single neurons or neuroblast clones (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S5<italic>A</italic></ext-link>). We found that wild type but not patient <italic>ACTL6B</italic> missense alleles quantitatively rescued targeting (<xref ref-type="fig" rid="fig02">Fig. 2 <italic>E</italic> and <italic>F</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, S5 <italic>B</italic> and <italic>C</italic></ext-link>), confirming that patient mutations show LoF in vivo and suggesting that altered synaptic specificity may contribute to the <italic>ACTL6B</italic> autism phenotype.</p>
</sec>
<sec id="s5">
<title>Defects in Callosal Anatomy in Humans and Mice Lacking ACTL6B.</title>
<p>Perfect dendritic retargeting in <italic>ACTL6B</italic> mutant flies may be mechanistically related to a distinctive clinical feature of BAF mutant ASD: reduced or absent corpus callosum (<xref ref-type="bibr" rid="r17">17</xref>, <xref ref-type="bibr" rid="r49">49</xref>). This defect involves a failure of axons to cross to the opposite cerebral hemisphere and is often associated with mutations in guidance molecules such as semaphorins, which also direct dendritic and axonal targeting in flies (<xref ref-type="bibr" rid="r50">50</xref><xref ref-type="bibr" rid="r51"></xref>–<xref ref-type="bibr" rid="r52">52</xref>). Hypogenesis of the corpus callosum may further reflect altered functional connectivity, as has been detected by resting-state functional MRI in some ASD patients (<xref ref-type="bibr" rid="r53">53</xref>, <xref ref-type="bibr" rid="r54">54</xref>). We compared available clinical brain MRIs (axial and midline sagittal) to identify evidence of altered brain anatomy in autistic patients with <italic>ACTL6B</italic> mutations. Compared with a healthy control, affected individuals showed reduced cerebral white matter volume and most showed corpus callosal hypoplasia (<xref ref-type="fig" rid="fig03">Fig. 3<italic>A</italic></xref>).</p>
<fig fig-type="figure" id="fig03" orientation="portrait" position="float">
<label>Fig. 3.</label>
<caption>
<p>Loss of <italic>ACTL6B</italic> causes corpus callosum hypoplasia in humans and mice. (<italic>A</italic>) Human brain MRI scans of control compared with <italic>ACTL6B</italic> mutated subjects. (<italic>Top</italic> row) Midline sagittal. White arrows: corpus callosum hypoplasia. (<italic>Bottom</italic> row) Axial images at the level of the foramen of Monroe showing paucity of white matter compared with control. (<italic>B</italic>) Adult mouse coronal brain slices from wild type, <italic>Actl6b</italic><sup><italic>+/−</italic></sup>, or <italic>Actl6b</italic><sup>−/−</sup> were stained with antibodies to neurofilament light chain (NFL) to visualize callosal axon tracks. Representative images of male wild-type, <italic>Actl6b</italic><sup><italic>+/−</italic></sup>, and <italic>Actl6b</italic><sup>−/−</sup> brain slices. <italic>Actl6b</italic><sup>−/−</sup> corpus callosum was visibly thinner, indicated with a white arrow. (<italic>C</italic>) Quantification of relative callosal thickness showing significantly thinner callosum in knockouts. Blinded measurements from <italic>n</italic> = 2 slices were averaged for each animal and compared for <italic>n</italic> = 4 mice per genotype. (<italic>D</italic>) Quantification of relative thickness of the somatosensory cortex in slices used for <italic>C</italic> showing no significant difference. Significance was assessed by ordinary one-way ANOVA with Tukey’s correction for multiple comparisons; <italic>F</italic><sub>(2,9)</sub> = 10.73 for <italic>C</italic>; <italic>F</italic><sub>(2,9)</sub> = 0.62 for <italic>D</italic>. Error bars indicate SEM. *<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ***<italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic id="gra3" xlink:href="pnas.1908238117fig03"></graphic>
</fig>
<p><italic>Actl6b</italic> knockout mice have thinner myelin sheaths (<xref ref-type="bibr" rid="r14">14</xref>), consistent with the reduction in white matter in <italic>ACTL6B</italic> patients. This prompted us to examine <italic>Actl6b</italic> knockout mice for evidence of reduced or absent corpus callosum. We immunostained coronal sections of adult mouse brain for neurofilament and measured relative corpus callosum thickness using ImageJ. <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice showed a ∼20% reduction in corpus callosum thickness compared to wild type (<xref ref-type="fig" rid="fig03">Fig. 3 <italic>B</italic> and <italic>C</italic></xref>). Heterozygous mice showed no difference in corpus callosum thickness, indicating that this is a recessive phenotype in mice. No significant differences in cortical thickness were observed (<xref ref-type="fig" rid="fig03">Fig. 3<italic>D</italic></xref>). Reduced corpus callosum volume has also been reported in mice lacking one copy of the ASD-related BAF subunit <italic>Arid1b</italic> (<xref ref-type="bibr" rid="r55">55</xref>). Thus, like other BAF subunits, <italic>ACTL6B</italic> is required for corpus callosum formation in humans and mice.</p>
</sec>
<sec id="s6">
<title><italic>Actl6b</italic><sup><italic>−/−</italic></sup> Mice Exhibit Autism-Related Behaviors in Two Genetic Backgrounds.</title>
<p>Because the patient mutations were LoF and <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice showed corpus callosum hypoplasia like <italic>ACTL6B</italic> patients, we asked whether <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice exhibit ASD-related behaviors. In 2007, we generated <italic>Actl6b</italic><sup>−/−</sup> mice with mixed 129/Sv; C57BL/6 background and found that few survived past weaning (<xref ref-type="bibr" rid="r14">14</xref>). Subsequent backcrossing over many generations to C57BL/6 produced litters with <italic>Actl6b</italic><sup>−/−</sup> at the expected 25% ratio and with most mice living to adulthood when provided with recovery gel after weaning. In parallel, a second cohort of <italic>Actl6b</italic><sup>+/−</sup> mice were crossed for many generations to either 129S6/SvEv or C57BL/6 strains at Fujita Health University, and the F<sub>1</sub> cross of these congenic strains also produced <italic>Actl6b</italic><sup>−/−</sup> mice that survived to adulthood. We conducted our behavioral characterization on both cohorts of <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice and their littermates separately, and then compared results after data were acquired.</p>
<p>We assessed social behavior, a hallmark of autism, using a juvenile interaction test and three-chamber sociability assay (<xref ref-type="fig" rid="fig04">Fig. 4 <italic>A</italic> and <italic>B</italic></xref>). The juvenile interaction test measured the amount of time 7-wk-old test mice spent interacting with a 4-wk-old juvenile wild-type mouse of the same sex. This revealed significant and gene dosage-dependent decreases in social interaction in both male and female C57BL/6 mice (<italic>P</italic> &lt; 0.0001 for male or female wild type vs. <italic>Actl6b</italic><sup><italic>+/−</italic></sup> or <italic>Actl6b</italic><sup><italic>−/−</italic></sup>, <italic>P</italic> = 0.011 for <italic>Actl6b</italic><sup><italic>+/−</italic></sup> vs. <italic>Actl6b</italic><sup><italic>−/−</italic></sup> males, <italic>P</italic> = 0.0047 for <italic>Actl6b</italic><sup><italic>+/−</italic></sup> vs. <italic>Actl6b</italic><sup><italic>−/−</italic></sup> females by one-way ANOVA; <xref ref-type="fig" rid="fig04">Fig. 4<italic>C</italic></xref>). These results were specific for social defects, because replacing the juvenile mouse with a novel toy mouse revealed no differences in interaction across genotypes (<xref ref-type="fig" rid="fig04">Fig. 4<italic>D</italic></xref>). Similarly, male knockout mice on C57BL/6 × 129S6/SvEv background showed significantly reduced social interactions with an adult mouse of the same sex and genotype (<italic>P</italic> = 0.0208, Student’s <italic>t</italic> test; <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6 <italic>A</italic> and <italic>B</italic></ext-link>), suggesting a role for <italic>Actl6b</italic> in murine social interaction that is independent of genetic background.</p>
<fig fig-type="figure" id="fig04" orientation="portrait" position="float">
<label>Fig. 4.</label>
<caption>
<p><italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice exhibit autism-related behaviors. (<italic>A</italic>) Social interaction and control tests: relative interaction time between the adult test mouse and a juvenile mouse (3–5 wk) or novel object. Open-field test measured activity over 20 min as total distance traveled. (<italic>B</italic>) Schematic of three-chamber sociability assay: Test mice may enter the zone with a novel object or the zone with a novel juvenile mouse. Social preference scores were calculated from time spent in each zone using the formula shown. (<italic>C</italic>) Box plots showing male and female littermates of <italic>Actl6b</italic><sup><italic>+/−</italic></sup> × <italic>Actl6b</italic><sup><italic>+/−</italic></sup> crosses with gene dosage-dependent impairment in social interaction with a juvenile mouse but not with (<italic>D</italic>) a control novel object. (<italic>E</italic>) <italic>Actl6b</italic><sup><italic>+/−</italic></sup> and <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice of both sexes showed defects in sociability, which were most severe in female knockouts. (<italic>F</italic>) Single, repeated photobeam breaks or “stereotypic counts” represented by a small red box in an open field. Male <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice showed repetitive movements indicated from increased stereotypic counts over 120 min. (<italic>G</italic>) Diagram of Barnes maze test of spatial memory: an elevated, white, circular open field containing 12 holes, with one “target” escape hole leading to a comfortable cage. Visual cues provided the mouse with a frame of reference for the location of the target hole. Male <italic>Actl6b</italic><sup>−/−</sup> mice spent less time around the target hole, indicating impaired memory as to the location of the target hole. (<italic>H</italic>) <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice of both sexes showed increased activity, not observed in <italic>Actl6b</italic><sup><italic>+/−</italic></sup>. Tests shown in <italic>C</italic>, <italic>E</italic>, and <italic>H</italic> were conducted at Stanford University on a cohort of mice highly backcrossed to the C57BL/6 background; mice (<sup>+/+</sup>, <sup>+/−</sup>, <sup>−/−</sup>): <italic>n</italic> = 9, 12, 7 males, <italic>n</italic> = 11, 12, 10 females for <italic>C</italic>; <italic>n</italic> = 10, 13, 6 males, <italic>n</italic> = 11, 12, 9 females for <italic>D</italic>; <italic>n</italic> = 10, 12, 7 males, <italic>n</italic> = 11, 12, 9 females for <italic>E</italic>; <italic>n</italic> = 10, 13, 6 males, <italic>n</italic> = 11, 11, 5 females for <italic>H</italic>. Values for each test in this cohort were as follows: <italic>F</italic><sub>(2,30)Females</sub> = 79.87 and <italic>F</italic><sub>(2,25)Males</sub> = 59.49 for <italic>C</italic>; <italic>F</italic><sub>(2,29)Females</sub> = 0.29 and <italic>F</italic><sub>(2,26)Males</sub> = 0.74 for <italic>D</italic>; <italic>F</italic><sub>(2,29)Females</sub> = 6.82 and <italic>F</italic><sub>(2,26)Males</sub> = 4.83 for <italic>E</italic>; and <italic>F</italic><sub>(2,24)Females</sub> = 13.44 and <italic>F</italic><sub>(2,26)Males</sub> = 8.60 for <italic>H</italic>. Stereotypic counts in <italic>F</italic> and spatial memory in <italic>G</italic> were assessed at Fujita Health University on adult male mice that were the F<sub>1</sub> offspring of a cross between <italic>Actl6b</italic><sup><italic>+/−</italic></sup> 129S6/SvEv × <italic>Actl6b</italic><sup><italic>+/−</italic></sup> C57BL/6. Mice (<sup>+/+</sup>, <sup>−/−</sup>): <italic>n</italic> = 22, 21 in <italic>F</italic>, and <italic>n</italic> = 22, 14 in <italic>G</italic>. Significance was calculated for <italic>B</italic>, <italic>E</italic>, and <italic>H</italic> using a one-way analysis of variance (ANOVA) with Tukey’s multiple-comparison post hoc. Significance for <italic>F</italic> and <italic>G</italic> was calculated using Student’s <italic>t</italic> test: <italic>t</italic><sub>41</sub> = 8.68 in <italic>F</italic> and <italic>t</italic><sub>34</sub> = 3.99 in <italic>G</italic>. Whiskers indicate 10th and 90th percentiles. *<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ***<italic>P</italic> &lt; 0.001; ****<italic>P</italic> &lt; 0.0001.</p>
</caption>
<graphic id="gra4" xlink:href="pnas.1908238117fig04"></graphic>
</fig>
<p>In the three-chamber assay for sociability, animals were given the choice of inhabiting a chamber containing a novel juvenile mouse in a cage or a novel, empty cage (<xref ref-type="fig" rid="fig04">Fig. 4<italic>B</italic></xref>). Social preference scores, calculated from the ratio of time spent in each chamber, indicated that <italic>Actl6b</italic><sup><italic>+/−</italic></sup> and <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice were less sociable compared to wild types (for males, <italic>P</italic> = 0.025 for wild type vs. <italic>Actl6b</italic><sup><italic>+/−</italic></sup> and <italic>P =</italic> 0.048 for wild type vs. <italic>Actl6b</italic><sup><italic>−/−</italic></sup>; for females, <italic>P</italic> = 0.038 for wild type vs. <italic>Actl6b</italic><sup><italic>+/−</italic></sup> and <italic>P =</italic> 0.0037 for wild type vs. <italic>Actl6b</italic><sup><italic>−/−</italic></sup> by one-way ANOVA; <xref ref-type="fig" rid="fig04">Fig. 4<italic>E</italic></xref>). Female mice exhibited a trend toward increasing social avoidance with decreasing <italic>Actl6b</italic> gene dosage. These results suggest a direct role for <italic>Actl6b</italic> in social interaction and sociability.</p>
<p>Patients with autism also display restricted or stereotypic (repeated) behaviors. We thus assessed stereotypy in the open-field test in male littermates (<italic>Actl6b</italic><sup><italic>+/−</italic></sup> 129S6/SvEv × <italic>Actl6b</italic><sup><italic>+/−</italic></sup> C57BL/6 F<sub>1</sub> cross) using repeated breaks of the same photobeam (stereotypic counts). <italic>Actl6b</italic><sup>−/−</sup> mice showed significantly elevated stereotypic counts, consistent with increased repetitive behaviors (<italic>P</italic> &lt; 0.0001, Student’s <italic>t</italic> test; <xref ref-type="fig" rid="fig04">Fig. 4<italic>F</italic></xref>).</p>
<p>ID affects 45% of all autism patients (<xref ref-type="bibr" rid="r30">30</xref>), is a consistent feature of BAF mutant ASD (<xref ref-type="bibr" rid="r17">17</xref>), and was present in affected individuals with <italic>ACTL6B</italic> mutations. We therefore conducted the Barnes maze test for spatial memory (<xref ref-type="fig" rid="fig04">Fig. 4<italic>G</italic></xref>) and the T-maze forced alternation test for working memory (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6<italic>C</italic></ext-link>). These forms of memory depend upon neural circuits involving the hippocampus and prefrontal cortex, respectively (<xref ref-type="bibr" rid="r56">56</xref>, <xref ref-type="bibr" rid="r57">57</xref>). Both tests revealed significant memory impairment in male <italic>Actl6b</italic><sup>−/−</sup> mice (129S6/SvEv × C57BL/6 F<sub>1</sub> cross) (<italic>P</italic> = 0.0003 for Barnes maze and <italic>P</italic> &lt; 0.0001 for T-maze forced alternation, Student’s <italic>t</italic> test; <xref ref-type="fig" rid="fig04">Fig. 4<italic>G</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6 <italic>D</italic> and <italic>E</italic></ext-link>), consistent with previous studies showing impaired hippocampal memory consolidation, striatum-dependent cocaine-conditioned place preference, and amygdala-based fear learning in heterozygous <italic>Actl6b</italic><sup>+/−</sup> mice (<xref ref-type="bibr" rid="r58">58</xref><xref ref-type="bibr" rid="r59"></xref>–<xref ref-type="bibr" rid="r60">60</xref>). We conclude that <italic>Actl6b</italic> is required for memory formation in multiple neuronal systems.</p>
<p>Hyperactivity and anxiety are common comorbidities in ASD that show bias toward males and females, respectively (<xref ref-type="bibr" rid="r30">30</xref>). However, all affected individuals with <italic>ACTL6B</italic> mutations showed hyperactivity. We recorded the location and distance mice traveled in an open field to assess anxiety and activity levels (<xref ref-type="fig" rid="fig04">Fig. 4<italic>A</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6<italic>F</italic></ext-link>). Male <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice showed no clear trend in anxiety as indicated from relative time spent in the open field center; however, female <italic>Actl6b</italic><sup><italic>−/−</italic></sup> were more anxious than their heterozygous or wild-type sisters (<italic>P</italic> = 0.0017 for <italic>Actl6b</italic><sup>−/−</sup> vs. <italic>Actl6b</italic><sup>+/−</sup> and <italic>P</italic> = 0.064 for <italic>Actl6b</italic><sup>−/−</sup> vs. wild type, one-way ANOVA; <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6 <italic>G</italic> and <italic>H</italic></ext-link>). Total distance traveled in the open field indicated that <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice of both cohorts and sexes traveled more than three times greater distance than their littermates, suggestive of a recessive hyperactive phenotype (<italic>P &lt;</italic> 0.001 in all comparisons to <italic>Actl6b</italic><sup>−/−</sup> for each sex, one-way ANOVA; <xref ref-type="fig" rid="fig04">Fig. 4<italic>H</italic></xref>, <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6 <italic>I</italic>–<italic>L</italic></ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Movies S2</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">S3</ext-link>). We conclude that <italic>Actl6b</italic><sup>−/−</sup> mice robustly model general autism-related behaviors and behaviors that are characteristic of <italic>ACTL6B</italic> mutant ASD.</p>
</sec>
<sec id="s7">
<title><italic>Actl6b</italic><sup><italic>−/−</italic></sup> nBAF Complexes Retain the Nonneuronal Variant Actl6a and Have Reduced Affinity for Neuronal Chromatin.</title>
<p>Having established conserved roles for <italic>ACTL6B</italic> in mammalian social behavior and neural circuit formation, we sought to uncover the molecular function of ACTL6B and explore disease-relevant mechanisms. In mouse and human, <italic>ACTL6B</italic> expression is restricted to neurons, with lower expression in testes (<xref ref-type="bibr" rid="r10">10</xref>, <xref ref-type="bibr" rid="r61">61</xref>). Previous studies have indicated that the majority of ACTL6B protein is likely associated with the nBAF complex (<xref ref-type="bibr" rid="r11">11</xref>, <xref ref-type="bibr" rid="r12">12</xref>, <xref ref-type="bibr" rid="r14">14</xref>). Because ACTL6B mutant proteins were not incorporated into nBAF complexes, we considered that the assembly of nBAF might be affected by the loss of Actl6b. We immunoprecipitated <italic>Actl6b</italic><sup><italic>−/−</italic></sup> or wild-type nBAF complexes with the J1 antibody, which recognizes both Smarca2 and Smarca4 (<xref ref-type="bibr" rid="r62">62</xref>), and then digested and labeled peptides with “heavy” ∆4 (<sup>13</sup>C<sup>15</sup>N) or “light” ∆0 (<sup>12</sup>C<sup>14</sup>N) mTRAQ reagent, respectively. Peptides from each complex were pooled 1:1 and analyzed by mass spectrometry, where +4-Da shifted peaks indicated <italic>Actl6b</italic><sup>−/−</sup> peptides (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>A</italic></ext-link>). Normalized automated statistical analysis of protein (ASAP) ratios of heavy knockout to light wild-type peptides were generated (Protein Prophet Probability cutoff &gt; 0.9) such that values &lt;1 indicated reduced interactions and &gt;1 indicated stabilized interactions in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> nBAF complexes (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7 <italic>B</italic>–<italic>D</italic></ext-link>). The total number of peptides from the pool of wild-type and knockout complexes was also recorded. Because BAF complexes are highly abundant in the nucleus (300,000 per cell), its interactions with low abundance proteins (e.g., transcription factors) of &lt;10,000 per cell are difficult to detect. Thus, we included proteins recovered as only a single peptide (<xref ref-type="bibr" rid="r62">62</xref>) as a resource, but with cautious interpretation.</p>
<p>Proteomic analysis of <italic>Actl6b</italic><sup><italic>−/−</italic></sup> nBAF complexes indicated complete assembly of nBAF subunits, with peptides specific to the nonneuronal homolog Actl6a recovered in place of Actl6b. The Actl6b ASAP ratio ∼2 and nearly equivalent peptide counts for Actl6a (in knockout) and Actl6b (in wild type) suggested that <italic>Actl6b</italic><sup><italic>−/−</italic></sup> nBAF complexes fully retain Actl6a (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>B</italic></ext-link>). Mutant nBAF complexes showed reduced interaction with the abundant chromatin protein histone H1 and with autism-related proteins including Kat6a/Myst3 and Adnp, both confirmed BAF interacting proteins (<xref ref-type="bibr" rid="r63">63</xref>, <xref ref-type="bibr" rid="r64">64</xref>) (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>C</italic></ext-link><bold>)</bold>. Several proteins exhibited stronger interactions with mutant than wild-type complexes (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>D</italic></ext-link>), including Wiz, a promoter binding protein previously linked to abnormal social behavior in mouse (<xref ref-type="bibr" rid="r65">65</xref>). The proteomic data indicate that Actl6b loss results in the formation of an abnormal nBAF complex containing Actl6a with reduced interactions with established binding partners and gained interactions with novel partners.</p>
<p>Actl6a and Actl6b proteins share 95% sequence similarity except in the 43-residue subdomain 2, which shows only 53% sequence similarity (<xref ref-type="bibr" rid="r66">66</xref>). We previously showed that Actl6a cannot rescue neuronal function of nBAF in <italic>Actl6b</italic><sup>−/−</sup> cells, and neither can a chimeric Actl6b containing the subdomain 2 of Actl6a (<xref ref-type="bibr" rid="r14">14</xref>). To confirm misincorporation of Actl6a into nBAF in the absence of Actl6b, we assessed Actl6a expression and incorporation into nBAF complexes in postnatal day 0 (P0) brain tissues from wild-type, <italic>Actl6b</italic><sup><italic>+/−</italic></sup>, or <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mouse littermates. We found elevated Actl6a protein in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> cerebellar whole-cell extracts and in nuclear extracts from hippocampal tissue at P0 (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7 <italic>E</italic> and <italic>G</italic></ext-link>). BAF complexes immunoprecipitated with nBAF-specific Ss18l1 antibody from P0 cerebellar, cortical, or hippocampal nuclear extracts showed <italic>Actl6b</italic> gene dosage-dependent increases in Actl6a incorporation (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7 <italic>F</italic> and <italic>G</italic></ext-link>). Given that microRNAs switch off Actl6a expression during neural differentiation (<xref ref-type="bibr" rid="r13">13</xref>), we tested whether the persistence of Actl6a in nBAF was transcriptionally mediated. In cultured primary cortical neurons, we found significantly increased (∼1.2-fold) <italic>Actl6a</italic> transcripts by RT-qPCR from <italic>Actl6b</italic><sup>−/−</sup> compared with wild type (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>H</italic></ext-link>). This observation suggested that Actl6a was retained in nBAF in part due to a failure to repress <italic>Actl6a</italic> transcription in postmitotic neurons.</p>
<p>To learn whether <italic>ACTL6A</italic> was transcriptionally up-regulated in affected human neurons, we measured expression in brain organoids, an improved culture method for modeling human brain development (<xref ref-type="bibr" rid="r67">67</xref>). We first confirmed that human brain organoids express ACTL6A and ACTL6B during maturation in controls at day 69 (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S8<italic>A</italic></ext-link>). Brain organoids from unaffected (<italic>ACTL6B</italic><sup><italic>+/L154F</italic></sup>) or two affected (<italic>ACTL6B</italic><sup><italic>L154F/L154F</italic></sup>) individuals of family 2703 were cultured to day 28 and harvested for RNA or immunostained for developmental markers of neural progenitors (Sox2) and immature neurons (Tuj1). No gross differences in development were observed between unaffected and affected brain organoids (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S8<italic>B</italic></ext-link>). However, brain organoids from two affected individuals displayed about a threefold increase in <italic>ACTL6A</italic> transcript compared to the unaffected control (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>I</italic></ext-link>). These data support a conserved mechanism in which <italic>ACTL6A</italic> expression is increased transcriptionally in the absence of functional ACTL6B, leading to the formation of an abnormal nBAF complex.</p>
<p>The incorporation of Actl6a into <italic>Actl6b</italic><sup><italic>−/−</italic></sup> nBAF was associated with reduced interactions between mutant complexes and histone H1 (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>C</italic></ext-link>), suggesting that mutant nBAF complexes may have abnormal interactions with chromatin. To test this, we fractionated chromatin from embryonic day 18.5 (E18.5)/day in vitro 7 (DIV7) wild-type vs. <italic>Actl6b</italic><sup>−/−</sup> cortical neurons using increasing concentrations of salt (300–700 mM NaCl) and blotted for nBAF in the resulting soluble nuclear or chromatin fractions. We found that <italic>Actl6b</italic><sup>−/−</sup> nBAF complexes were not as stably associated with chromatin as wild type across a wide range of salt concentrations (<xref ref-type="bibr" rid="r68">68</xref>) (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S7<italic>J</italic></ext-link>), suggesting impaired BAF–chromatin interactions as a result of altered nBAF constituency.</p>
</sec>
<sec id="s8">
<title>ACTL6B Suppresses the Activity-Responsive Transcriptional Program in Resting Neurons.</title>
<p><italic>Actl6b</italic> is required in neurons for activity-dependent dendritic outgrowth and long-term potentiation (<xref ref-type="bibr" rid="r14">14</xref>, <xref ref-type="bibr" rid="r58">58</xref>), processes that require transcription and facilitate learning and memory (<xref ref-type="bibr" rid="r69">69</xref>). Targeted chromatin immunoprecipitation experiments in neurons have suggested that nBAF complexes are bound to the promoter of the immediate early gene <italic>Fos</italic> and may regulate its expression (<xref ref-type="bibr" rid="r70">70</xref>). However, genome-wide expression studies in postmitotic neurons have yielded inconsistent insights into the molecular function of Actl6b and the neuronal BAF complex (<xref ref-type="bibr" rid="r58">58</xref>, <xref ref-type="bibr" rid="r71">71</xref>).</p>
<p>To clarify the role of ACTL6B in transcriptional regulation, we conducted RNA-seq and ATAC sequencing (ATAC-seq) on primary cortical neurons from wild-type or <italic>Actl6b</italic><sup><italic>−/−</italic></sup> E16.5 embryos cultured for 7 DIV (<xref ref-type="bibr" rid="r72">72</xref>). Neurons from <italic>n</italic> = 5 wild-type and <italic>n</italic> = 7 knockout biological replicates (littermates) were collected after 2-h treatment with TTX/APV, which silenced network activity in order to reflect the resting state (<xref ref-type="bibr" rid="r73">73</xref>). RNA libraries were prepared from a fraction of the neurons in each biological sample, while another fraction was transposed with Tn5 to cut and tag accessible chromatin for sequencing (ATAC-seq) (<xref ref-type="bibr" rid="r74">74</xref>) (<xref ref-type="fig" rid="fig05">Fig. 5<italic>A</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Datasets S1</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">S2</ext-link>). The quality of collected data were confirmed by principal-component analysis, which demonstrated separation of biological samples by genotype in both RNA-seq and ATAC-seq datasets (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S9 <italic>A</italic> and <italic>B</italic></ext-link>). We also confirmed <italic>Actl6b</italic> deletion in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S9<italic>C</italic></ext-link>).</p>
<fig fig-type="figure" id="fig05" orientation="portrait" position="float">
<label>Fig. 5.</label>
<caption>
<p><italic>ACTL6B</italic> suppresses the activity-responsive transcriptional program in resting neurons. (<italic>A</italic>) Experimental design: Primary E16.5/DIV7 cortical cultures from (<italic>n</italic> = 5) wild-type or (<italic>n</italic> = 7) <italic>Actl6b</italic><sup><italic>−/−</italic></sup> littermates were treated for 2 h with TTX/APV to silence action potentials and represent the “resting” neuronal state. RNA was collected to measure transcription by RNA-seq and DNA was transposed with Tn5 to measure chromatin accessibility by ATAC-seq. (<italic>B</italic>) MA plot of transcriptional changes in resting <italic>Actl6b</italic><sup>−/−</sup> (KO) neurons relative to wild type (WT). Differentially expressed genes showing FDR &lt; 5% and absolute log<sub>2</sub> fold change &gt;0.5 were defined as “significant” and highlighted in red. Gene names are shown for the top 30 most significant genes. (<italic>C</italic>) Transcription factor coexpression analysis was performed on the significantly up- or down-regulated genes in resting <italic>Actl6b</italic><sup><italic>−/−</italic></sup> (KO) neurons. Up-regulated genes commonly coexpress with early response transcription factors such as <italic>Jun</italic>, <italic>Nr4a2</italic>, and <italic>Fosb</italic>, indicating possible activity-dependent transcription factor activity. (<italic>D</italic>) Heat maps showing log<sub>2</sub> fold changes for genes that were both significantly differentially expressed in resting <italic>Actl6b</italic><sup><italic>−/−</italic></sup> (KO) neurons and in wild-type (WT) neurons that were stimulated for 1 or 6 h with 55 mM KCl. Early response genes showed altered expression after 1-h KCl stimulation in wild type (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S10<italic>A</italic></ext-link>) and late response genes showed altered expression after 6-h KCl stimulation in wild type (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S10<italic>B</italic></ext-link>). Representative genes from each group are labeled. Transcriptional changes in resting <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons significantly correlated with activity-induced responses in wild type. (<italic>E</italic>) mRNA expression of activity-responsive genes in the biological samples used for RNA-seq, measured by RT-qPCR. AP1 transcription factors <italic>Fos</italic>, <italic>Fosb</italic>, <italic>Fosl2</italic>, and their late response target gene <italic>Vgf</italic> were significantly increased in resting <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons. (<italic>F</italic>) mRNA expression of activity-responsive genes in 28-d-old cerebral brain organoids cultured from induced pluripotent cells of an unaffected father (<italic>ACTL6B</italic><sup><italic>L154F/+</italic></sup>) and his two affected children (<italic>ACTL6B</italic><sup><italic>L154F/L154F</italic></sup>) in family 2703, measured by RT-qPCR; <italic>n</italic> = 3 technical replicates per individual. AP1 transcription factors <italic>FOS</italic>, <italic>FOSB</italic>, <italic>FOSL2</italic>, <italic>JUN</italic>, and their late response target gene <italic>VGF</italic> were significantly increased in affected human brain organoids. (<italic>G</italic>) Chromatin accessibility was assayed by ATAC-seq as described in <italic>A</italic>, and HOMER de novo motif analysis was performed on the significantly increased or decreased sites in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> (KO) neurons. Sites with increased chromatin accessibility were selectively enriched for the AP1 transcription factor binding motif, indicated by FRA1. (<italic>H</italic>) Summary model: Autism mutant ACTL6B “B” proteins are unstable and rapidly degraded, leading to retention of the nonneuronal homolog ACTL6A “A” in the nBAF complex. The loss of <italic>ACTL6B</italic> relieves transcriptional repression on early response transcription factors but increases repression on repetitive elements in resting neurons. mRNAs encoding early response transcription factors, particularly those in the AP1 family, are translated into proteins that regulate the expression of late response neuronal genes. Multisubunit nBAF complexes containing ubiquitously expressed subunits (gray), a core ATPase subunit (dark blue), neuronal-specific subunits (yellow), and neural-progenitor subunit ACTL6A (purple). AP1 transcription factor proteins are shown in pink. Balls on a string indicate nucleosomes. The arrow represents transcriptional activation; T represents transcriptional repression. Dashed lines in <italic>H</italic> indicate that the mechanism of repression may be direct or indirect. Significance was calculated by Spearman rank correlation in <italic>D</italic>, individual Student’s <italic>t</italic> tests in <italic>E</italic>, and two-way analysis of variance (ANOVA) in <italic>F</italic>. Error bars indicate SEM. *<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ***<italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic id="gra5" xlink:href="pnas.1908238117fig05"></graphic>
</fig>
<p>Comparing mRNA expression in wild-type vs. <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons, we identified 503 genes with increased expression and 383 genes with reduced expression in the absence of <italic>Actl6b</italic> (false-discovery rate [FDR] &lt; 5%; absolute log<sub>2</sub> fold change &gt; 0.5) (<xref ref-type="fig" rid="fig05">Fig. 5<italic>B</italic></xref>). Gene coexpression analysis revealed that down-regulated genes frequently coexpress with <italic>ZNF821</italic> (<xref ref-type="fig" rid="fig05">Fig. 5<italic>C</italic></xref>), a transcription factor that was previously linked to methamphetamine-associated psychosis (<xref ref-type="bibr" rid="r75">75</xref>). Up-regulated genes in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> frequently coexpress with early response transcription factors <italic>Nr4a2</italic> and members of the AP1 family including <italic>Fosb</italic> and <italic>Jun</italic>. This was surprising because early response transcription factors are normally expressed at very low levels in resting neurons. During neural activity, they are rapidly induced and subsequently regulate the expression of “late response” genes, which encode proteins that support neural plasticity (<xref ref-type="bibr" rid="r76">76</xref>).</p>
<p>The results from coexpression analysis prompted us to explore a connection between transcriptional changes in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> and transcriptional changes due to neural activity. To define activity-responsive genes, we conducted RNA-seq on wild-type E16.5/DIV7 cortical cultures that were silenced with TTX/APV for 1 h and then stimulated for 1 or 6 h with 55 mM KCl to model neural activity (<italic>n = </italic>5 biological replicates each for 1-h KCl and 1-h control, <italic>n</italic> = 3 for 6-h KCl, and <italic>n</italic> = 4 for 6 h control). In wild-type mice, we identified 534 up-regulated and 237 down-regulated “early response” genes at 1-h KCl; and 2,603 up-regulated and 2,287 down-regulated late response genes at 6-h KCl (FDR &lt; 5%, absolute log<sub>2</sub> fold change &gt; 0.5) (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S10 <italic>A</italic> and <italic>B</italic></ext-link>). Over 40% of differentially expressed genes in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons could be classified as “activity responsive” (<xref ref-type="fig" rid="fig05">Fig. 5<italic>D</italic></xref><bold>)</bold>. Of the 66 early response genes that were differentially expressed in resting <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons, 94% followed a pattern of expression expected during neural activity (Spearman correlation coefficient <italic>r</italic><sub><italic>s</italic></sub> = 0.53, <italic>P</italic> = 7.3 × 10<sup>−6</sup>; <xref ref-type="fig" rid="fig05">Fig. 5<italic>D</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S10<italic>C</italic></ext-link>). Up-regulated genes in resting <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons included immediate early transcription factors <italic>Fos</italic>, <italic>Fosb</italic>, <italic>Fosl2</italic>, <italic>Junb</italic>, <italic>Nr4a2</italic>, <italic>Npas4</italic>, <italic>Arc</italic>, <italic>Egr1</italic>, <italic>Egr2</italic>, <italic>Egr4</italic>, and <italic>Klf10</italic> (<xref ref-type="fig" rid="fig05">Fig. 5<italic>D</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Dataset S1</ext-link>).</p>
<p>A predicted consequence of immediate early transcription factor activation is that late response genes will show an expression pattern mimicking activity. Of 365 late response genes that were differentially expressed in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons, 84% were altered as if by activity (Spearman correlation coefficient = 0.61; <italic>P &lt;</italic> 2.2 × 10<sup>−16</sup>, <xref ref-type="fig" rid="fig05">Fig. 5<italic>D</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S10<italic>D</italic></ext-link>). Expression changes in early and late response genes were validated by RT-qPCR in E16.5/DIV7 murine cortical cultures (<xref ref-type="fig" rid="fig05">Fig. 5<italic>E</italic></xref>) and in 65-d-old brain organoids derived from affected individuals in family 2703 (<italic>ACTL6B</italic><sup><italic>L154F/L154F</italic></sup><italic>)</italic> (<xref ref-type="fig" rid="fig05">Fig. 5<italic>F</italic></xref>). These findings indicate a conserved role for ACTL6B in suppressing the activity-responsive transcriptional program in resting neurons.</p>
<p>A functional readout for chromatin remodeling activity and transcription factor binding is chromatin accessibility, which we measured by ATAC-seq. Accessible sites in resting neurons were predominantly found in intergenic and intronic regions, with ∼20% in promoters (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S11<italic>A</italic></ext-link>). Chromatin was more accessible in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> than in wild-type neurons, with 843 sites showing increased accessibility and 174 sites showing reduced accessibility (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S11<italic>B</italic></ext-link>). To learn which DNA binding proteins might occupy differentially accessible sites, we conducted de novo motif analysis using HOMER. Sites with increased accessibility in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons were significantly and selectively enriched for the AP1 transcription factor motif (<xref ref-type="fig" rid="fig05">Fig. 5<italic>G</italic></xref>), consistent with increased expression of AP1 subunits <italic>Fos</italic>, <italic>Fosb</italic>, <italic>Fosl2</italic>, and <italic>Junb.</italic> These sites were disproportionally located at distal intergenic regions, suggestive of enhancer activation (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S11<italic>C</italic></ext-link>). Decreased sites were modestly enriched for DNA binding proteins <italic>Hoxa3</italic>, <italic>Nfia</italic>, <italic>Mef2a</italic>, and <italic>Ctcf</italic> (<xref ref-type="fig" rid="fig05">Fig. 5<italic>G</italic></xref>), and were inordinately found in introns (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S11<italic>D</italic></ext-link>). The profound enrichment of AP1 motifs at gained accessible sites suggested increased AP1 transcription factor activity in resting <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons.</p>
<p>To learn how elevated early response gene expression in resting <italic>Actl6b</italic><sup>−/−</sup> neurons affected transcriptional responses to neural activity, we measured mRNA levels for activity-responsive genes in wild-type or <italic>Actl6b</italic><sup><italic>−/−</italic></sup> E16.5/DIV7 cortical cultures stimulated with or without KCl, as above. KCl stimulation induced the expression of immediate early genes and reduced the expression of <italic>Txnip</italic> in wild-type neurons, as expected (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S12<italic>A</italic></ext-link>). However, the expression of activity-regulated genes in <italic>Actl6b</italic><sup>−/−</sup> neurons was significantly higher than in wild type (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S12<italic>B</italic></ext-link>). Thus, early response gene expression was abnormally elevated in resting and active <italic>Actl6b</italic><sup>−/−</sup> neurons.</p>
<p>Repetitive element transcription has been used as a measure of global transcriptional noise in resting neurons (<xref ref-type="bibr" rid="r77">77</xref>). However, neural activity can also induce repetitive element transcription (<xref ref-type="bibr" rid="r78">78</xref>). To test whether increased early response gene expression in <italic>Actl6b</italic><sup>−/−</sup> neurons was associated with global transcriptional noise, we measured repetitive element transcripts in wild-type or <italic>Actl6b</italic><sup>−/−</sup> neurons shown in <xref ref-type="fig" rid="fig05">Fig. 5<italic>E</italic></xref>, whose network activity had been blocked for 2 h with TTX/APV. Intriguingly, repetitive element transcript levels were reduced in <italic>Actl6b</italic><sup>−/−</sup> neurons compared to wild type (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S12<italic>C</italic></ext-link>). Following 1-h KCl stimulation, repetitive element transcripts were strongly induced in wild-type but not in <italic>Actl6b</italic><sup>−/−</sup> neurons, resulting in much lower expression of repetitive elements in <italic>Actl6b</italic><sup>−/−</sup> neurons in the context of neural activity (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S12<italic>D</italic></ext-link>). These results indicate that early response gene activation in <italic>Actl6b</italic><sup>−/−</sup> neurons was not a consequence of globally increased transcriptional noise. Rather, early response genes were specifically de-repressed while repetitive elements were more silenced in the absence of Actl6b.</p>
<p>Since activity-dependent transcription is required for long-term memory formation (<xref ref-type="bibr" rid="r69">69</xref>, <xref ref-type="bibr" rid="r76">76</xref>), the inappropriate activation of activity responsive genes in resting <italic>Actl6b</italic><sup>−/−</sup> neurons is a plausible explanation for impaired memory in <italic>Actl6b</italic> mutant mice (<xref ref-type="fig" rid="fig04">Fig. 4<italic>G</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6 <italic>C</italic>–<italic>E</italic></ext-link>) (<xref ref-type="bibr" rid="r58">58</xref><xref ref-type="bibr" rid="r59"></xref>–<xref ref-type="bibr" rid="r60">60</xref>, <xref ref-type="bibr" rid="r79">79</xref>) and in affected humans (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Table S1</ext-link>) (<xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r40">40</xref>, <xref ref-type="bibr" rid="r41">41</xref>, <xref ref-type="bibr" rid="r44">44</xref>, <xref ref-type="bibr" rid="r45">45</xref>, <xref ref-type="bibr" rid="r80">80</xref><xref ref-type="bibr" rid="r81"></xref>–<xref ref-type="bibr" rid="r82">82</xref>). However, it is unclear whether this mechanism can account for other aspects of the <italic>ACTL6B</italic> patient phenotype, such as social deficits or corpus callosum hypogenesis. To gain deeper insight into the molecular changes in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons and how these relate to aspects of the <italic>ACTL6B</italic> mutant phenotype, we used the Enrichr (<xref ref-type="bibr" rid="r83">83</xref>, <xref ref-type="bibr" rid="r84">84</xref>) tool to perform a set of enrichment analyses on up-regulated and down-regulated genes in mutant neurons. The most enriched term for molecular functions of up-regulated genes in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons was transcription factor activity, consistent with the DNA binding activity of many early response genes (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S13<italic>A</italic></ext-link>). Enrichment analysis for down-regulated genes highlighted terms related to the nucleosome remodeling and histone deacetylase (NuRD) complex, semaphorin signaling, and genes involved in ion balance. These terms are consistent with altered chromatin repression, impaired axon guidance, and seizure activity, respectively.</p>
<p>Biological pathway analysis revealed that up-regulated genes in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons were involved in neuroactive ligand–receptor interactions and in serotonin and anxiety-related events (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S13 <italic>B</italic> and <italic>C</italic></ext-link>). Genes associated with these terms included stress-related corticotrophin releasing hormone (<italic>Crh</italic>, also known as CRF) and its receptor <italic>Crhr1</italic>, as well as serotonin receptors 1b (<italic>Htr1b</italic>), 2c (<italic>Htr2c</italic>), and 3a (<italic>Htr3a</italic>). CRF administration can induce seizures in rats (<xref ref-type="bibr" rid="r85">85</xref>), and both CRF and serotonin have been implicated in memory and social behaviors (<xref ref-type="bibr" rid="r86">86</xref>, <xref ref-type="bibr" rid="r87">87</xref>). Pathway analysis of down-regulated genes identified roles in axon guidance and fatty acid biosynthesis, in line with callosal defects and loss of white matter observed in <italic>ACTL6B</italic> mutant humans and mice (<xref ref-type="fig" rid="fig03">Fig. 3 <italic>A</italic>–<italic>C</italic></xref>). Enrichment analysis thus revealed potential mechanisms underlying the corpus callosum defects, seizures, memory, and social impairments in <italic>ACTL6B</italic> mutant humans and mice.</p>
</sec>
</sec>
<sec id="s9" sec-type="discussion">
<title>Discussion</title>
<p content-type="flushleft">We identified <italic>ACTL6B</italic> as the most significantly mutated gene in the SRAC, indicating that mutations in this gene may be a relatively common cause of recessive autism. In line with this finding, <italic>ACTL6B</italic> was the sixth most significantly mutated gene out of 409 genes with recessive missense variants in the Autism Sequencing Consortium (<xref ref-type="bibr" rid="r25">25</xref>), and recent case studies have identified individuals with biallelic <italic>ACTL6B</italic> variants showing similar recessive neurodevelopmental phenotypes to the patients we describe. Severe epilepsy, ID, lack of speech, developmental delays, feeding difficulties, microcephaly, hypomyelination, and corpus callosum hypogenesis were consistent clinical features associated with <italic>ACTL6B</italic> LoF (<xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r40">40</xref>, <xref ref-type="bibr" rid="r41">41</xref>, <xref ref-type="bibr" rid="r44">44</xref>, <xref ref-type="bibr" rid="r45">45</xref>, <xref ref-type="bibr" rid="r82">82</xref>). One patient was diagnosed with Rett syndrome (<xref ref-type="bibr" rid="r82">82</xref>). Several patients passed away before 10 y of age (<xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r41">41</xref>). Patients were not uniformly diagnosed with autism, possibly due to the severity of the phenotype or to differences in diagnostic criteria. <italic>ACTL6B</italic> mutations segregated perfectly with recessive phenotypes in a variety of genetic backgrounds (Middle Eastern, French Canadian, Finnish, Sicilian) and in children of both consanguineous and nonconsanguinous parents, affirming high penetrance.</p>
<p>Interestingly, two dominant <italic>ACTL6B</italic> alleles (G343R or D77G) were recently identified in patients with autism who did not experience seizures but otherwise exhibited characteristics of the recessive <italic>ACTL6B</italic> patients (<xref ref-type="bibr" rid="r29">29</xref>). In a separate study of genetic causes of ID, two affected individuals were found to have inherited the G343R mutation from their intellectually disabled father (<xref ref-type="bibr" rid="r80">80</xref>). The dominant G343R mutation was also identified as a de novo mutation in large screens for genetic causes of developmental delays, ID, and seizures (<xref ref-type="bibr" rid="r81">81</xref>, <xref ref-type="bibr" rid="r88">88</xref>, <xref ref-type="bibr" rid="r89">89</xref>). These dominant alleles may act on the wild-type copy protein or may poison the function of the nBAF complex, although further work is needed to explore these possibilities. In addition, one patient diagnosed with ASD was found to have a postzygotic mosaic, synonymous mutation in <italic>ACTL6B</italic> (<xref ref-type="bibr" rid="r90">90</xref>). Including the present study, there are at least 38 recessively affected and 19 dominantly affected individuals documented with ASD-related phenotypes caused by mutations in <italic>ACTL6B</italic> (<xref ref-type="bibr" rid="r25">25</xref>, <xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r40">40</xref>, <xref ref-type="bibr" rid="r41">41</xref>, <xref ref-type="bibr" rid="r44">44</xref>, <xref ref-type="bibr" rid="r45">45</xref>, <xref ref-type="bibr" rid="r80">80</xref><xref ref-type="bibr" rid="r81"></xref>–<xref ref-type="bibr" rid="r82">82</xref>, <xref ref-type="bibr" rid="r90">90</xref>, <xref ref-type="bibr" rid="r91">91</xref>).</p>
<p>Deletion of the fly ortholog of <italic>ACTL6B</italic> in olfactory projection neurons resulted in cell-autonomous rewiring of the olfactory system in a manner that might cause the fly to misinterpret chemical social cues. Altered semaphorin signaling may underlie this defect, as deletion of <italic>Sema1a</italic> in fly olfactory neurons results in similar but less specific dendritic retargeting to <italic>ACTL6B</italic> mutants (<xref ref-type="bibr" rid="r47">47</xref>, <xref ref-type="bibr" rid="r50">50</xref>) and we found that semaphorin genes (<italic>Sema4c</italic>, <italic>Sema4g</italic>, <italic>Sema6c</italic>) and their receptors (<italic>Plxna3</italic>, <italic>Plxnb1</italic>, <italic>Plxnc1</italic>) showed reduced expression in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> neurons. Polymorphisms in <italic>PLXNA3</italic> have been identified in individuals with abnormal postnatal corpus callosum development (<xref ref-type="bibr" rid="r92">92</xref>) and <italic>Plxnb1/2</italic> double-knockout mice exhibit corpus callosum agenesis (<xref ref-type="bibr" rid="r93">93</xref>), suggesting a connection with the callosum hypogenesis we observed in humans and mice lacking <italic>ACTL6B</italic>.</p>
<p>We also found that <italic>Actl6b</italic> knockout mice exhibit similar behaviors to <italic>ACTL6B</italic> patients, including social behavior deficits, increased repetitive movements, memory impairments, and hyperactivity. Autism mouse models 16p11.2, <italic>Shank3</italic>, <italic>Cntnap2</italic>, <italic>Pten</italic>, <italic>Tsc1</italic>, <italic>En2</italic>, and <italic>Gabrb3</italic>, show similar deficits to <italic>Actl6b</italic> knockout mice in the juvenile interaction and three-chamber assays (<xref ref-type="bibr" rid="r32">32</xref>, <xref ref-type="bibr" rid="r87">87</xref>, <xref ref-type="bibr" rid="r94">94</xref>), but unlike some of these models, behaviors in <italic>Actl6b</italic><sup><italic>−/−</italic></sup> mice were robust on two genetic backgrounds. Hyperactivity and callosal defects showed recessive inheritance, while the severity of social behavior deficits increased with decreasing <italic>Actl6b</italic> gene dosage. Previous studies showed memory defects in heterozygous mice (<xref ref-type="bibr" rid="r58">58</xref><xref ref-type="bibr" rid="r59"></xref>–<xref ref-type="bibr" rid="r60">60</xref>), suggesting dosage sensitivity; however, the heterozygous relatives of patients here showed no overt symptoms.</p>
<p>Approximately 40% of gene expression changes in electrically silenced <italic>Actl6b</italic><sup>−/−</sup> neurons reflected transcriptional responses to neural activity, indicating that the de-repression of early response transcription factors like AP1 may be a primary defect in <italic>ACTL6B</italic> mutant neurons (<xref ref-type="fig" rid="fig05">Fig. 5<italic>H</italic></xref>). Similarly, heterozygous mutations in the BAF ATPase <italic>SMARCA2</italic> that cause autism-related Nicolaides–Baraitser syndrome were found to de-repress <italic>FOSL2</italic> and lead to AP1 pioneer factor activity and BAF recruitment to enhancers in human neural progenitor cells (<xref ref-type="bibr" rid="r95">95</xref>). That mutation of either <italic>ACTL6B</italic> or <italic>SMARCA2</italic> results in elevated AP1 expression suggests that the mechanism for de-repression involves a functional breakdown of the BAF complex. This is consistent with the fact that BAF mutations cause similar forms of ASD (<xref ref-type="bibr" rid="r23">23</xref>, <xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r96">96</xref>). We speculate that abnormal AP1 activation may be a common mechanism in BAF mutant ASD.</p>
<p>In summary, we show that LoF mutations in <italic>ACTL6B</italic> cause recessive autism in humans, patient-related phenotypes in mice and flies, and abnormal expression of early response genes, repetitive elements, semaphorins, CRF, and serotonin receptors in mouse neurons. The mechanism may involve the formation of nBAF complexes containing the nonneuronal homolog Actl6a, which have reduced affinity for neuronal chromatin. The genetic background and gender dependence of many genes implicated in autism have made biochemical analysis difficult because one would expect that any biochemical event underlying behavior would be subject to undetermined variables. In contrast, the gender and genetic background independence of <italic>ACTL6B</italic> mutations in both humans and mice should provide a powerful model for analysis of the role of chromatin regulation in autism.</p>
</sec>
<sec id="s10" sec-type="materials|methods">
<title>Materials and Methods</title>
<p content-type="flushleft">This study was approved by the institutional review boards of University of California, San Diego, for human subjects, and by the animal review board of Stanford University and Fujita Health University. Blood, skin punch, and clinical data were obtained from research subjects after obtaining informed consent. Detailed description of the patient clinical history, generation of iPSCs, methods for study of <italic>Bap55</italic> fly model using MARCM, behavioral assessment of mouse <italic>Actl6b</italic> mutants, primary neuronal cultures, transcriptional and proteome profiling, and assessment of chromatin are provided in <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Supplementary Text</ext-link>.</p>
<sec id="s11">
<title>Data Availability.</title>
<p>Exome-sequencing data from individuals in this study have been deposited to the Database of Genotypes and Phenotypes (dbGaP) under accession number phs000288.v2.p2. <italic>BAF53b</italic> and <italic>ACTL6B</italic> are used interchangeably. The GenBank accession ID is NR_134539.1. Raw RNA- and ATAC-seq data have been deposited in the Gene Expression Omnibus under GSE147056. The processed RNA-seq dataset is included as <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Dataset S1</ext-link> and ATAC-seq as <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Dataset S2</ext-link>. <italic>Bap55</italic> mutant flies expressing autism mutants for MARCM, patient-derived iPS cells, <italic>ACTL6B</italic> mutant plasmids, α-ACTL6A/B antibodies, and other resources developed or used in the paper are available upon request.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data">
<label>Supplementary File</label>
<media xlink:href="pnas.1908238117.sapp.pdf"></media>
</supplementary-material>
<supplementary-material content-type="local-data">
<label>Supplementary File</label>
<media xlink:href="pnas.1908238117.sm01.mp4"></media>
</supplementary-material>
<supplementary-material content-type="local-data">
<label>Supplementary File</label>
<media xlink:href="pnas.1908238117.sm02.mp4"></media>
</supplementary-material>
<supplementary-material content-type="local-data">
<label>Supplementary File</label>
<media xlink:href="pnas.1908238117.sm03.mp4"></media>
</supplementary-material>
<supplementary-material content-type="local-data">
<label>Supplementary File</label>
<media xlink:href="pnas.1908238117.sd01.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data">
<label>Supplementary File</label>
<media xlink:href="pnas.1908238117.sd02.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data">
<label>Supplementary File</label>
<media xlink:href="pnas.1908238117.sd03.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Lei Chen, Alex Valdefiera, and Claire M. Ellis for their help with mouse breeding. We thank Kyle Loh, Lay Teng Ang, Alon Goren, and Ian Maze for thoughtful discussion. This work was supported by Simons Foundation for Autism Research Grant 514863 (to J.G.G. and G.R.C.); National Institutes of Health Grant NS046789 (to G.R.C.); Grant R01NS048453 and Qatar National Research Fund National Priorities Research Program Grant 6-1463-3-351 (to J.G.G. and T.B.-O.); Grants 1F31MH116588-01 and 2T32GM007790-38 (to W.W.); Grant 5T32GM008666 (to S.G.); and Grants U54HG003067 (to the Broad Institute) and U54HG006504 (to the Yale Center for Mendelian Disorders). Behavior studies were supported by grants from the Wu Tsai Neurosciences Institute and NIH P50 DA042012 (to R.C.M. and J.J.W.) and by the Joint Usage/Research Center for Genes, Brain and Behavior (Institute for Comprehensive Medical Science, Fujita Health University) accredited by the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.S. and T.M.). J.G.G., G.R.C., and L.L. are investigators with the Howard Hughes Medical Institute. J.G.G. received support from Rady Children’s Institute for Genomic Medicine.</p>
</ack>
<fn-group>
<fn fn-type="COI-statement">
<p>Competing interest statement: G.R.C. is a founder of Foghorn Therapeutics.</p>
</fn>
<fn fn-type="other">
<p>This article is a PNAS Direct Submission.</p>
</fn>
<fn fn-type="other">
<p>Data deposition: The exome-sequencing data from individuals in this study have been deposited in the Database of Genotypes and Phenotypes (dbGaP), <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gap/">https://www.ncbi.nlm.nih.gov/gap/</ext-link> (accession no. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000288.v2.p2">phs000288.v2.p2</ext-link>) and are available upon reasonable request. The raw RNA- and ATAC-sequencing data have been deposited in the Gene Expression Omnibus (GEO) database, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo" xlink:show="new">https://www.ncbi.nlm.nih.gov/geo</ext-link> (accession no. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147056">GSE147056</ext-link>). The processed RNA-sequencing dataset is included as <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Dataset S1</ext-link> and ATAC-sequencing dataset as <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">Dataset S2</ext-link>.</p>
</fn>
<fn fn-type="supplementary-material">
<p>This article contains supporting information online at <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental" xlink:show="new">https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1908238117/-/DCSupplemental</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<ref id="r1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baio</surname><given-names>J.</given-names></name><etal></etal></person-group>, <article-title>Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2014</article-title>. <source/>MMWR Surveill. Summ.
<volume>67</volume>, <fpage>1</fpage>–<lpage>23</lpage> (<year>2018</year>).</mixed-citation>
</ref>
<ref id="r2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsabbagh</surname><given-names>M.</given-names></name><etal></etal></person-group>, <article-title>Global prevalence of autism and other pervasive developmental disorders</article-title>. <source/>Autism Res.
<volume>5</volume>, <fpage>160</fpage>–<lpage>179</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22495912</pub-id></mixed-citation>
</ref>
<ref id="r3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>D.</given-names></name><etal></etal></person-group>, <article-title>Association of genetic and environmental factors with autism in a 5-country cohort</article-title>. <source/>JAMA Psychiatry, <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.1411</pub-id> (<year>2019</year>).</mixed-citation>
</ref>
<ref id="r4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abrahams</surname><given-names>B. S.</given-names></name><etal></etal></person-group>, <article-title>SFARI gene 2.0: A community-driven knowledgebase for the autism spectrum disorders (ASDs)</article-title>. <source/>Mol. Autism
<volume>4</volume>, <fpage>36</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24090431</pub-id></mixed-citation>
</ref>
<ref id="r5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodges</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kirkland</surname><given-names>J. G.</given-names></name>, <name name-style="western"><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group>, <article-title>The many roles of BAF (mSWI/SNF) and PBAF complexes in cancer</article-title>. <source/>Cold Spring Harb. Perspect. Med.
<volume>6</volume>, <fpage>a026930</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27413115</pub-id></mixed-citation>
</ref>
<ref id="r6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>E. L.</given-names></name><etal></etal></person-group>, <article-title>TOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>24</volume>, <fpage>344</fpage>–<lpage>352</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28250416</pub-id></mixed-citation>
</ref>
<ref id="r7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadoch</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group>, <article-title>Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma</article-title>. <source/>Cell
<volume>153</volume>, <fpage>71</fpage>–<lpage>85</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23540691</pub-id></mixed-citation>
</ref>
<ref id="r8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadoch</surname><given-names>C.</given-names></name><etal></etal></person-group>, <article-title>Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>213</fpage>–<lpage>222</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27941796</pub-id></mixed-citation>
</ref>
<ref id="r9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stanton</surname><given-names>B. Z.</given-names></name><etal></etal></person-group>, <article-title>Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>282</fpage>–<lpage>288</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27941795</pub-id></mixed-citation>
</ref>
<ref id="r10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olave</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group>, <article-title>Identification of a polymorphic, neuron-specific chromatin remodeling complex</article-title>. <source/>Genes Dev.
<volume>16</volume>, <fpage>2509</fpage>–<lpage>2517</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12368262</pub-id></mixed-citation>
</ref>
<ref id="r11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lessard</surname><given-names>J.</given-names></name><etal></etal></person-group>, <article-title>An essential switch in subunit composition of a chromatin remodeling complex during neural development</article-title>. <source/>Neuron
<volume>55</volume>, <fpage>201</fpage>–<lpage>215</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17640523</pub-id></mixed-citation>
</ref>
<ref id="r12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staahl</surname><given-names>B. T.</given-names></name><etal></etal></person-group>, <article-title>Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>10348</fpage>–<lpage>10361</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23785148</pub-id></mixed-citation>
</ref>
<ref id="r13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoo</surname><given-names>A. S.</given-names></name>, <name name-style="western"><surname>Staahl</surname><given-names>B. T.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group>, <article-title>MicroRNA-mediated switching of chromatin-remodelling complexes in neural development</article-title>. <source/>Nature
<volume>460</volume>, <fpage>642</fpage>–<lpage>646</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19561591</pub-id></mixed-citation>
</ref>
<ref id="r14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J. I.</given-names></name><etal></etal></person-group>, <article-title>Regulation of dendritic development by neuron-specific chromatin remodeling complexes</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>94</fpage>–<lpage>108</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17920018</pub-id></mixed-citation>
</ref>
<ref id="r15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aizawa</surname><given-names>H.</given-names></name><etal></etal></person-group>, <article-title>Dendrite development regulated by CREST, a calcium-regulated transcriptional activator</article-title>. <source/>Science
<volume>303</volume>, <fpage>197</fpage>–<lpage>202</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">14716005</pub-id></mixed-citation>
</ref>
<ref id="r16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Son</surname><given-names>E. Y.</given-names></name>, <name name-style="western"><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group>, <article-title>The role of BAF (mSWI/SNF) complexes in mammalian neural development</article-title>. <source/>Am. J. Med. Genet. C. Semin. Med. Genet.
<volume>166C</volume>, <fpage>333</fpage>–<lpage>349</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25195934</pub-id></mixed-citation>
</ref>
<ref id="r17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kosho</surname><given-names>T.</given-names></name><etal></etal></person-group>, <article-title>Clinical correlations of mutations affecting six components of the SWI/SNF complex: Detailed description of 21 patients and a review of the literature</article-title>. <source/>Am. J. Med. Genet. A.
<volume>161A</volume>, <fpage>1221</fpage>–<lpage>1237</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23637025</pub-id></mixed-citation>
</ref>
<ref id="r18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyakawa</surname><given-names>T.</given-names></name><etal></etal></person-group>, <article-title>Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components</article-title>. <source/>Hippocampus
<volume>11</volume>, <fpage>763</fpage>–<lpage>775</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11811671</pub-id></mixed-citation>
</ref>
<ref id="r19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bramswig</surname><given-names>N. C.</given-names></name><etal></etal></person-group>, <article-title>Heterozygosity for ARID2 loss-of-function mutations in individuals with a Coffin-Siris syndrome-like phenotype</article-title>. <source/>Hum. Genet.
<volume>136</volume>, <fpage>297</fpage>–<lpage>305</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28124119</pub-id></mixed-citation>
</ref>
<ref id="r20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dias</surname><given-names>C.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>DDD Study</collab></person-group>, <article-title>BCL11A haploinsufficiency causes an intellectual disability syndrome and dysregulates transcription</article-title>. <source/>Am. J. Hum. Genet.
<volume>99</volume>, <fpage>253</fpage>–<lpage>274</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27453576</pub-id></mixed-citation>
</ref>
<ref id="r21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>E. T.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>Autism Sequencing Consortium</collab></person-group>, <article-title>Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>1217</fpage>–<lpage>1224</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28714951</pub-id></mixed-citation>
</ref>
<ref id="r22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neale</surname><given-names>B. M.</given-names></name><etal></etal></person-group>, <article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders</article-title>. <source/>Nature
<volume>485</volume>, <fpage>242</fpage>–<lpage>245</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22495311</pub-id></mixed-citation>
</ref>
<ref id="r23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vasileiou</surname><given-names>G.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>Deciphering Developmental Disorders Study</collab></person-group>, <article-title>Mutations in the BAF-complex subunit DPF2 are associated with coffin-Siris syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>102</volume>, <fpage>468</fpage>–<lpage>479</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29429572</pub-id></mixed-citation>
</ref>
<ref id="r24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nixon</surname><given-names>K. C. J.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>DDD Study</collab></person-group>, <article-title>A syndromic neurodevelopmental disorder caused by mutations in SMARCD1, a core SWI/SNF subunit needed for context-dependent neuronal gene regulation in flies</article-title>. <source/>Am. J. Hum. Genet.
<volume>104</volume>, <fpage>596</fpage>–<lpage>610</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30879640</pub-id></mixed-citation>
</ref>
<ref id="r25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doan</surname><given-names>R. N.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>Autism Sequencing Consortium</collab></person-group>, <article-title>Recessive gene disruptions in autism spectrum disorder</article-title>. <source/>Nat. Genet.
<volume>51</volume>, <fpage>1092</fpage>–<lpage>1098</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31209396</pub-id></mixed-citation>
</ref>
<ref id="r26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wieczorek</surname><given-names>D.</given-names></name><etal></etal></person-group>, <article-title>A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling</article-title>. <source/>Hum. Mol. Genet.
<volume>22</volume>, <fpage>5121</fpage>–<lpage>5135</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23906836</pub-id></mixed-citation>
</ref>
<ref id="r27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marom</surname><given-names>R.</given-names></name><etal></etal></person-group>, <article-title>Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability</article-title>. <source/>Hum. Mutat.
<volume>38</volume>, <fpage>1365</fpage>–<lpage>1371</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28649782</pub-id></mixed-citation>
</ref>
<ref id="r28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuvertino</surname><given-names>S.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>DDD Study</collab></person-group>, <article-title>ACTB loss-of-function mutations result in a pleiotropic developmental disorder</article-title>. <source/>Am. J. Hum. Genet.
<volume>101</volume>, <fpage>1021</fpage>–<lpage>1033</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29220674</pub-id></mixed-citation>
</ref>
<ref id="r29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bell</surname><given-names>S.</given-names></name><etal></etal></person-group>, <article-title>Mutations in ACTL6B cause neurodevelopmental deficits and epilepsy and lead to loss of dendrites in human neurons</article-title>. <source/>Am. J. Hum. Genet.
<volume>104</volume>, <fpage>815</fpage>–<lpage>834</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31031012</pub-id></mixed-citation>
</ref>
<ref id="r30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeste</surname><given-names>S. S.</given-names></name>, <name name-style="western"><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group>, <article-title>Disentangling the heterogeneity of autism spectrum disorder through genetic findings</article-title>. <source/>Nat. Rev. Neurol.
<volume>10</volume>, <fpage>74</fpage>–<lpage>81</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24468882</pub-id></mixed-citation>
</ref>
<ref id="r31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>López</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>M. A.</given-names></name></person-group>, <article-title>Role of nucleosome remodeling in neurodevelopmental and intellectual disability disorders</article-title>. <source/>Front. Behav. Neurosci.
<volume>9</volume>, <fpage>100</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25954173</pub-id></mixed-citation>
</ref>
<ref id="r32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellegood</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Crawley</surname><given-names>J. N.</given-names></name></person-group>, <article-title>Behavioral and neuroanatomical phenotypes in mouse models of autism</article-title>. <source/>Neurotherapeutics
<volume>12</volume>, <fpage>521</fpage>–<lpage>533</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26036957</pub-id></mixed-citation>
</ref>
<ref id="r33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rylaarsdam</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Guemez-Gamboa</surname><given-names>A.</given-names></name></person-group>, <article-title>Genetic causes and modifiers of autism spectrum disorder</article-title>. <source/>Front. Cell. Neurosci.
<volume>13</volume>, <fpage>385</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31481879</pub-id></mixed-citation>
</ref>
<ref id="r34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarlungeanu</surname><given-names>D. C.</given-names></name><etal></etal></person-group>, <article-title>Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder</article-title>. <source/>Cell
<volume>167</volume>, <fpage>1481</fpage>–<lpage>1494.e18</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27912058</pub-id></mixed-citation>
</ref>
<ref id="r35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Novarino</surname><given-names>G.</given-names></name><etal></etal></person-group>, <article-title>Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy</article-title>. <source/>Science
<volume>338</volume>, <fpage>394</fpage>–<lpage>397</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22956686</pub-id></mixed-citation>
</ref>
<ref id="r36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansen</surname><given-names>A.</given-names></name><etal></etal></person-group>, <article-title>Mutations in MBOAT7, encoding lysophosphatidylinositol acyltransferase I, lead to intellectual disability accompanied by epilepsy and autistic features</article-title>. <source/>Am. J. Hum. Genet.
<volume>99</volume>, <fpage>912</fpage>–<lpage>916</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27616480</pub-id></mixed-citation>
</ref>
<ref id="r37">
<label>37</label>
<mixed-citation publication-type="web-page"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><etal></etal></person-group>, <article-title>Whole exome and whole genome sequencing of human families with recessive autism</article-title>. Database of Genotypes and Phenotypes (dbGaP). <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000288.v2.p2">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000288.v2.p2</ext-link>. Deposited 22 June <year>2010</year>.</mixed-citation>
</ref>
<ref id="r38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silverstein</surname><given-names>R. L.</given-names></name>, <name name-style="western"><surname>Febbraio</surname><given-names>M.</given-names></name></person-group>, <article-title>CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior</article-title>. <source/>Sci. Signal.
<volume>2</volume>, <fpage>re3</fpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19471024</pub-id></mixed-citation>
</ref>
<ref id="r39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faber</surname><given-names>I.</given-names></name><etal></etal></person-group>, <article-title><italic>SPG11</italic> mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage</article-title>. <source/>Neuroimage Clin.
<volume>19</volume>, <fpage>848</fpage>–<lpage>857</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29946510</pub-id></mixed-citation>
</ref>
<ref id="r40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yüksel</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yazol</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gümüş</surname><given-names>E.</given-names></name></person-group>, <article-title>Pathogenic homozygous variations in ACTL6B cause DECAM syndrome: Developmental delay, epileptic encephalopathy, cerebral Atrophy, and abnormal myelination</article-title>. <source/>Am. J. Med. Genet. A.
<volume>179</volume>, <fpage>1603</fpage>–<lpage>1608</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31134736</pub-id></mixed-citation>
</ref>
<ref id="r41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fichera</surname><given-names>M.</given-names></name><etal></etal></person-group>, <article-title>Mutations in ACTL6B, coding for a subunit of the neuron-specific chromatin remodeling complex nBAF, cause early onset severe developmental and epileptic encephalopathy with brain hypomyelination and cerebellar atrophy</article-title>. <source/>Hum. Genet.
<volume>138</volume>, <fpage>187</fpage>–<lpage>198</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30656450</pub-id></mixed-citation>
</ref>
<ref id="r42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lek</surname><given-names>M.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>Exome Aggregation Consortium</collab></person-group>, <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature
<volume>536</volume>, <fpage>285</fpage>–<lpage>291</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="r43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>E. M.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>Greater Middle East Variome Consortium</collab></person-group>, <article-title>Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery</article-title>. <source/>Nat. Genet.
<volume>48</volume>, <fpage>1071</fpage>–<lpage>1076</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27428751</pub-id></mixed-citation>
</ref>
<ref id="r44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maddirevula</surname><given-names>S.</given-names></name><etal></etal></person-group>, <article-title>Autozygome and high throughput confirmation of disease genes candidacy</article-title>. <source/>Genet. Med.
<volume>21</volume>, <fpage>736</fpage>–<lpage>742</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30237576</pub-id></mixed-citation>
</ref>
<ref id="r45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karaca</surname><given-names>E.</given-names></name><etal></etal></person-group>, <article-title>Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease</article-title>. <source/>Neuron
<volume>88</volume>, <fpage>499</fpage>–<lpage>513</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26539891</pub-id></mixed-citation>
</ref>
<ref id="r46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><etal></etal></person-group>, <article-title>Hierarchical chemosensory regulation of male-male social interactions in <italic>Drosophila</italic></article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>757</fpage>–<lpage>762</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21516101</pub-id></mixed-citation>
</ref>
<ref id="r47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tea</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>L.</given-names></name></person-group>, <article-title>The chromatin remodeling factor Bap55 functions through the TIP60 complex to regulate olfactory projection neuron dendrite targeting</article-title>. <source/>Neural Dev.
<volume>6</volume>, <fpage>5</fpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21284845</pub-id></mixed-citation>
</ref>
<ref id="r48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>L.</given-names></name></person-group>, <article-title>A protocol for mosaic analysis with a repressible cell marker (MARCM) in <italic>Drosophila</italic></article-title>. <source/>Nat. Protoc.
<volume>1</volume>, <fpage>2583</fpage>–<lpage>2589</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">17406512</pub-id></mixed-citation>
</ref>
<ref id="r49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sokpor</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Rosenbusch</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tuoc</surname><given-names>T.</given-names></name></person-group>, <article-title>Chromatin remodeling BAF (SWI/SNF) complexes in neural development and disorders</article-title>. <source/>Front. Mol. Neurosci.
<volume>10</volume>, <fpage>243</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28824374</pub-id></mixed-citation>
</ref>
<ref id="r50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komiyama</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>L. B.</given-names></name>, <name name-style="western"><surname>Schuldiner</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>K. C.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>L.</given-names></name></person-group>, <article-title>Graded expression of semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons</article-title>. <source/>Cell
<volume>128</volume>, <fpage>399</fpage>–<lpage>410</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17254975</pub-id></mixed-citation>
</ref>
<ref id="r51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Battum</surname><given-names>E. Y.</given-names></name>, <name name-style="western"><surname>Brignani</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pasterkamp</surname><given-names>R. J.</given-names></name></person-group>, <article-title>Axon guidance proteins in neurological disorders</article-title>. <source/>Lancet Neurol.
<volume>14</volume>, <fpage>532</fpage>–<lpage>546</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25769423</pub-id></mixed-citation>
</ref>
<ref id="r52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>H. H.</given-names></name>, <name name-style="western"><surname>Araj</surname><given-names>H. H.</given-names></name>, <name name-style="western"><surname>Ralls</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Kolodkin</surname><given-names>A. L.</given-names></name></person-group>, <article-title>The transmembrane Semaphorin Sema I is required in <italic>Drosophila</italic> for embryonic motor and CNS axon guidance</article-title>. <source/>Neuron
<volume>20</volume>, <fpage>207</fpage>–<lpage>220</lpage> (<year>1998</year>).<pub-id pub-id-type="pmid">9491983</pub-id></mixed-citation>
</ref>
<ref id="r53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hull</surname><given-names>J. V.</given-names></name><etal></etal></person-group>, <article-title>Resting-state functional connectivity in autism spectrum disorders: A review</article-title>. <source/>Front. Psychiatry
<volume>7</volume>, <fpage>205</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28101064</pub-id></mixed-citation>
</ref>
<ref id="r54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liska</surname><given-names>A.</given-names></name><etal></etal></person-group>, <article-title>Homozygous loss of autism-risk gene CNTNAP2 results in reduced local and long-range prefrontal functional connectivity</article-title>. <source/>Cereb. Cortex
<volume>28</volume>, <fpage>1141</fpage>–<lpage>1153</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">28184409</pub-id></mixed-citation>
</ref>
<ref id="r55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celen</surname><given-names>C.</given-names></name><etal></etal></person-group>, <article-title><italic>Arid1b</italic> haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment</article-title>. <source/>eLife
<volume>6</volume>, <fpage>e25730</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28695822</pub-id></mixed-citation>
</ref>
<ref id="r56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O’Leary</surname><given-names>T. P.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>R. E.</given-names></name></person-group>, <article-title>Optimization of apparatus design and behavioral measures for the assessment of visuo-spatial learning and memory of mice on the Barnes maze</article-title>. <source/>Learn. Mem.
<volume>20</volume>, <fpage>85</fpage>–<lpage>96</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23322557</pub-id></mixed-citation>
</ref>
<ref id="r57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNab</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Klingberg</surname><given-names>T.</given-names></name></person-group>, <article-title>Prefrontal cortex and basal ganglia control access to working memory</article-title>. <source/>Nat. Neurosci.
<volume>11</volume>, <fpage>103</fpage>–<lpage>107</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18066057</pub-id></mixed-citation>
</ref>
<ref id="r58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogel-Ciernia</surname><given-names>A.</given-names></name><etal></etal></person-group>, <article-title>The neuron-specific chromatin regulatory subunit BAF53b is necessary for synaptic plasticity and memory</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>552</fpage>–<lpage>561</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23525042</pub-id></mixed-citation>
</ref>
<ref id="r59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>A. O.</given-names></name><etal></etal></person-group>, <article-title>BDNF rescues BAF53b-dependent synaptic plasticity and cocaine-associated memory in the nucleus accumbens</article-title>. <source/>Nat. Commun.
<volume>7</volume>, <fpage>11725</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27226355</pub-id></mixed-citation>
</ref>
<ref id="r60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoo</surname><given-names>M.</given-names></name><etal></etal></person-group>, <article-title>BAF53b, a neuron-specific nucleosome remodeling factor, is induced after learning and facilitates long-term memory consolidation</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>3686</fpage>–<lpage>3697</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28270570</pub-id></mixed-citation>
</ref>
<ref id="r61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>X.</given-names></name><etal></etal></person-group>, <article-title>Generation of BAF53b-Cre transgenic mice with pan-neuronal Cre activities</article-title>. <source/>Genesis
<volume>53</volume>, <fpage>440</fpage>–<lpage>448</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26077106</pub-id></mixed-citation>
</ref>
<ref id="r62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>L.</given-names></name><etal></etal></person-group>, <article-title>An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>106</volume>, <fpage>5181</fpage>–<lpage>5186</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19279220</pub-id></mixed-citation>
</ref>
<ref id="r63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arboleda</surname><given-names>V. A.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>UCLA Clinical Genomics Center</collab></person-group>, <article-title>De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay</article-title>. <source/>Am. J. Hum. Genet.
<volume>96</volume>, <fpage>498</fpage>–<lpage>506</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25728775</pub-id></mixed-citation>
</ref>
<ref id="r64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandeweyer</surname><given-names>G.</given-names></name><etal></etal></person-group>, <article-title>The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism</article-title>. <source/>Am. J. Med. Genet. C. Semin. Med. Genet.
<volume>166C</volume>, <fpage>315</fpage>–<lpage>326</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25169753</pub-id></mixed-citation>
</ref>
<ref id="r65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isbel</surname><given-names>L.</given-names></name><etal></etal></person-group>, <article-title>Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse</article-title>. <source/>eLife
<volume>5</volume>, <fpage>e15082</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27410475</pub-id></mixed-citation>
</ref>
<ref id="r66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>J.</given-names></name><etal></etal></person-group>, <article-title>Sequence and comparative genomic analysis of actin-related proteins</article-title>. <source/>Mol. Biol. Cell
<volume>16</volume>, <fpage>5736</fpage>–<lpage>5748</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16195354</pub-id></mixed-citation>
</ref>
<ref id="r67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arlotta</surname><given-names>P.</given-names></name></person-group>, <article-title>Organoids required! A new path to understanding human brain development and disease</article-title>. <source/>Nat. Methods
<volume>15</volume>, <fpage>27</fpage>–<lpage>29</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29298289</pub-id></mixed-citation>
</ref>
<ref id="r68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakayama</surname><given-names>R. T.</given-names></name><etal></etal></person-group>, <article-title>SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>1613</fpage>–<lpage>1623</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28945250</pub-id></mixed-citation>
</ref>
<ref id="r69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alberini</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Kandel</surname><given-names>E. R.</given-names></name></person-group>, <article-title>The regulation of transcription in memory consolidation</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>7</volume>, <fpage>a021741</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25475090</pub-id></mixed-citation>
</ref>
<ref id="r70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Ghosh</surname><given-names>A.</given-names></name></person-group>, <article-title>A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression</article-title>. <source/>Neuron
<volume>60</volume>, <fpage>775</fpage>–<lpage>787</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">19081374</pub-id></mixed-citation>
</ref>
<ref id="r71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><etal></etal></person-group>, <article-title>Autism-associated chromatin regulator Brg1/SmarcA4 is required for synapse development and myocyte enhancer factor 2-mediated synapse remodeling</article-title>. <source/>Mol. Cell Biol.
<volume>36</volume>, <fpage>70</fpage>–<lpage>83</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26459759</pub-id></mixed-citation>
</ref>
<ref id="r72">
<label>72</label>
<mixed-citation publication-type="web-page"><person-group person-group-type="author"><name name-style="western"><surname>Wenderski</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Krokhotin</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group>, Loss of the neural-specific BAF subunit ACTL6B relieves repression of early response genes and causes recessive autism. Gene Expression Omnibus. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147056">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147056</ext-link>. Deposited 17 May <year>2020</year>.</mixed-citation>
</ref>
<ref id="r73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maze</surname><given-names>I.</given-names></name><etal></etal></person-group>, <article-title>Critical role of histone turnover in neuronal transcription and plasticity</article-title>. <source/>Neuron
<volume>87</volume>, <fpage>77</fpage>–<lpage>94</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26139371</pub-id></mixed-citation>
</ref>
<ref id="r74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buenrostro</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Giresi</surname><given-names>P. G.</given-names></name>, <name name-style="western"><surname>Zaba</surname><given-names>L. C.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>H. Y.</given-names></name>, <name name-style="western"><surname>Greenleaf</surname><given-names>W. J.</given-names></name></person-group>, <article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title>. <source/>Nat. Methods
<volume>10</volume>, <fpage>1213</fpage>–<lpage>1218</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24097267</pub-id></mixed-citation>
</ref>
<ref id="r75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breen</surname><given-names>M. S.</given-names></name><etal></etal></person-group>, <article-title>Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: An integrative RNA-sequencing report</article-title>. <source/>Transl. Psychiatry
<volume>6</volume>, <fpage>e802</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27163203</pub-id></mixed-citation>
</ref>
<ref id="r76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yap</surname><given-names>E. L.</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>M. E.</given-names></name></person-group>, <article-title>Activity-regulated transcription: Bridging the gap between neural activity and behavior</article-title>. <source/>Neuron
<volume>100</volume>, <fpage>330</fpage>–<lpage>348</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30359600</pub-id></mixed-citation>
</ref>
<ref id="r77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skene</surname><given-names>P. J.</given-names></name><etal></etal></person-group>, <article-title>Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state</article-title>. <source/>Mol. Cell
<volume>37</volume>, <fpage>457</fpage>–<lpage>468</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20188665</pub-id></mixed-citation>
</ref>
<ref id="r78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noh</surname><given-names>K. M.</given-names></name><etal></etal></person-group>, <article-title>ATRX tolerates activity-dependent histone H3 methyl/phos switching to maintain repetitive element silencing in neurons</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>112</volume>, <fpage>6820</fpage>–<lpage>6827</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25538301</pub-id></mixed-citation>
</ref>
<ref id="r79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Τ.</given-names></name><etal></etal></person-group>, <article-title>Histone methyltransferase Ash1L mediates activity-dependent repression of neurexin-1α</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>26597</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27229316</pub-id></mixed-citation>
</ref>
<ref id="r80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lecoquierre</surname><given-names>F.</given-names></name><etal></etal></person-group>, <article-title>Variant recurrence in neurodevelopmental disorders: The use of publicly available genomic data identifies clinically relevant pathogenic missense variants</article-title>. <source/>Genet. Med.
<volume>21</volume>, <fpage>2504</fpage>–<lpage>2511</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31036916</pub-id></mixed-citation>
</ref>
<ref id="r81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lelieveld</surname><given-names>S. H.</given-names></name><etal></etal></person-group>, <article-title>Spatial clustering of de novo missense mutations identifies candidate neurodevelopmental disorder-associated genes</article-title>. <source/>Am. J. Hum. Genet.
<volume>101</volume>, <fpage>478</fpage>–<lpage>484</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28867141</pub-id></mixed-citation>
</ref>
<ref id="r82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sajan</surname><given-names>S. A.</given-names></name><etal></etal></person-group>, <article-title>Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2</article-title>. <source/>Genet. Med.
<volume>19</volume>, <fpage>13</fpage>–<lpage>19</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27171548</pub-id></mixed-citation>
</ref>
<ref id="r83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>E. Y.</given-names></name><etal></etal></person-group>, <article-title>Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool</article-title>. <source/>BMC Bioinformatics
<volume>14</volume>, <fpage>128</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23586463</pub-id></mixed-citation>
</ref>
<ref id="r84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuleshov</surname><given-names>M. V.</given-names></name><etal></etal></person-group>, <article-title>Enrichr: A comprehensive gene set enrichment analysis web server 2016 update</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>W90</fpage>–<lpage>W97</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27141961</pub-id></mixed-citation>
</ref>
<ref id="r85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>S. R.</given-names></name><etal></etal></person-group>, <article-title>CRF-induced seizures and behavior: Interaction with amygdala kindling</article-title>. <source/>Brain Res.
<volume>372</volume>, <fpage>345</fpage>–<lpage>351</lpage> (<year>1986</year>).<pub-id pub-id-type="pmid">3486694</pub-id></mixed-citation>
</ref>
<ref id="r86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hupalo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Berridge</surname><given-names>C. W.</given-names></name></person-group>, <article-title>Working memory impairing actions of corticotropin-releasing factor (CRF) neurotransmission in the prefrontal cortex</article-title>. <source/>Neuropsychopharmacology
<volume>41</volume>, <fpage>2733</fpage>–<lpage>2740</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27272767</pub-id></mixed-citation>
</ref>
<ref id="r87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>J. J.</given-names></name><etal></etal></person-group>, <article-title>5-HT release in nucleus accumbens rescues social deficits in mouse autism model</article-title>. <source/>Nature
<volume>560</volume>, <fpage>589</fpage>–<lpage>594</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30089910</pub-id></mixed-citation>
</ref>
<ref id="r88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heyne</surname><given-names>H. O.</given-names></name><etal></etal></person-group>; <person-group person-group-type="author"><collab>EuroEPINOMICS RES Consortium</collab></person-group>, <article-title>De novo variants in neurodevelopmental disorders with epilepsy</article-title>. <source/>Nat. Genet.
<volume>50</volume>, <fpage>1048</fpage>–<lpage>1053</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29942082</pub-id></mixed-citation>
</ref>
<ref id="r89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Deciphering Developmental Disorders Study</collab></person-group>, <article-title>Prevalence and architecture of de novo mutations in developmental disorders</article-title>. <source/>Nature
<volume>542</volume>, <fpage>433</fpage>–<lpage>438</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28135719</pub-id></mixed-citation>
</ref>
<ref id="r90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krupp</surname><given-names>D. R.</given-names></name><etal></etal></person-group>, <article-title>Exonic mosaic mutations contribute risk for autism spectrum disorder</article-title>. <source/>Am. J. Hum. Genet.
<volume>101</volume>, <fpage>369</fpage>–<lpage>390</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28867142</pub-id></mixed-citation>
</ref>
<ref id="r91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Deciphering Developmental Disorders Study</collab></person-group>, <article-title>Large-scale discovery of novel genetic causes of developmental disorders</article-title>. <source/>Nature
<volume>519</volume>, <fpage>223</fpage>–<lpage>228</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25533962</pub-id></mixed-citation>
</ref>
<ref id="r92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belyk</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kraft</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>S.</given-names></name></person-group>; <person-group person-group-type="author"><collab>Pediatric Imaging, Neurocognition and Genetics Study</collab></person-group>, <article-title>PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure</article-title>. <source/>J. Hum. Genet.
<volume>60</volume>, <fpage>147</fpage>–<lpage>150</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25518740</pub-id></mixed-citation>
</ref>
<ref id="r93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daviaud</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Friedel</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>H.</given-names></name></person-group>, <article-title>Impaired cortical neurogenesis in plexin-B1 and -B2 double deletion mutant</article-title>. <source/>Dev. Neurobiol.
<volume>76</volume>, <fpage>882</fpage>–<lpage>899</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26579598</pub-id></mixed-citation>
</ref>
<ref id="r94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bey</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y. H.</given-names></name></person-group>, <article-title>Overview of mouse models of autism spectrum disorders</article-title>. <source/>Curr. Protoc. Pharmacol.
<volume>66</volume>, <fpage>5.66.1</fpage>-<lpage>5.66.26</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25181011</pub-id></mixed-citation>
</ref>
<ref id="r95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>F.</given-names></name><etal></etal></person-group>, <article-title>Heterozygous mutations in SMARCA2 reprogram the enhancer landscape by global retargeting of SMARCA4</article-title>. <source/>Mol. Cell
<volume>75</volume>, <fpage>891</fpage>–<lpage>904.e7</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31375262</pub-id></mixed-citation>
</ref>
<ref id="r96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsurusaki</surname><given-names>Y.</given-names></name><etal></etal></person-group>, <article-title>Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome</article-title>. <source/>Nat. Genet.
<volume>44</volume>, <fpage>376</fpage>–<lpage>378</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22426308</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>